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Abstract 
 
INVESTIGATING THE IN VIVO ROLE OF WNT ACYLATION 
Kelsey Foss Speer 
Peter S. Klein  
Mark A. Lemmon 
 
Wnts are a family of morphogens that play diverse roles in embryonic patterning, the 
maintenance of adult stem cells, and the evolution of cancers. Mammalian genomes 
contain 19 unique Wnt proteins which undergo post-translational acylation at a highly-
conserved serine residue. All Wnts bind to the Frizzled (Fz) family of seven-pass 
transmembrane receptor at an extracellular cysteine-rich domain (CRD). Recent 
crystallographic evidence suggests that interaction between Wnt and CRD is dependent 
upon the direct binding of an acyl group on the Wnt to a hydrophobic groove on the 
CRD. As all vertebrate Wnts are acylated at a conserved site, it is predicted that all Wnts 
will require acylation to recognize Fzs at the cell surface. However, this hypothesis has 
not been systematically tested. To address this gap in our understanding, I investigated 
the role of acylation in the signaling of Wnts in vivo. I hypothesized that if acylation were 
required for receptor binding, then preventing acylation would abolish the biological 
activity of these ligands. I tested my hypothesis in Xenopus laevis embryos competent to 
respond to the ectopic expression of Wnts. Surprisingly, I found that Wnt8 and Wnt3a 
were capable of robust signaling in vivo even when acylation was prevented. Both 
ligands also retained the ability to bind to the CRD of Fz8, suggesting that receptor 
recognition can occur through both acylation-dependent and acylation-independent 
mechanisms. In contrast, Wnts 1 and 5a required acylation to signal in Xenopus 
embryos. These findings challenge the assumption that acylation is absolutely required 
for the biological activity of Wnts. Furthermore, they reveal that Wnts have unique 
dependencies on acylation for their signaling roles in vivo, which may arise due to 
unique mechanisms of receptor activation. 
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Chapter 1: Introduction 
1.1. Wnts engage a diverse array of cell surface receptors 
Wnts are an ancient family of extracellular ligands required for the patterning and 
maintenance of the vertebrate body plan. Nineteen Wnts, with different expression 
patterns and physiological roles, exist in the mammalian proteome 
(http://web.stanford.edu/group/nusselab/cgi-bin/wnt/). These ligands control cell identity, 
differentiation, proliferation, survival, polarity and migration in different contexts (Clevers, 
2006). The regulation of such a wide range of cell processes is dependent upon the 
engagement of a diverse set of cell surface receptors (Niehrs, 2012). Unravelling Wnt 
signaling has proven challenging based upon the complexity of receptor interactions and 
technical limitations that have precluded the purification and study of components in 
vitro. However, our current understanding suggests that Wnts are multivalent proteins 
that physically crosslink unique receptors to form heterodimeric complexes at the cell 
surface (Bourhis et al., 2010; Janda et al., 2017). The ability of Wnts to “mix and match” 
these cell surface receptors appears to dictate which intracellular signaling responses 
occur.  
Most Wnt signaling occurs through the Frizzled (Fz) family of seven-pass 
transmembrane receptor (Figure 1.1, Bhanot et al., 1996). The Fz family, consisting of 
ten members, shares the conserved domain architecture of the G-protein coupled 
receptor (GPCR) superfamily (Schulte and Bryja, 2007). Like GPCRs, the intracellular 
loops of the transmembrane domain and the C-tail serve as docking sites for intracellular 
effectors (MacDonald and He, 2012). Of particular importance is the highly-conserved 
KTXXW motif (Wong et al., 2003) that provides an essential binding site for the 
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intracellular effector Dishevelled (Cong et al., 2004). Fzs also contain a large N-terminal 
domain, called the cysteine-rich domain (CRD), that projects into the extracellular space 
(Vinson et al., 1989; Byrne et al., 2016) and is both necessary and sufficient for Wnt 
binding (Bhanot et al., 1996; Hsieh et al., 1999). The only crystallographic evidence we 
currently have for Wnt binding to a receptor is of Xenopus laevis (x)Wnt8 bound to the 
CRD of murine (m)Fz8 (Figure 1.4, Janda et al., 2012). The structure supports the 
hypothesis that Wnts are asymmetric ligands that may crosslink a CRD-containing 
receptor with a co-receptor. However, as of yet, there has been no in vivo validation of 
the observed binding interfaces and the significance of this structure to the biology of 
Wnts remains unclear.  
The receptors LRP5 and 6, members of the low-density lipoprotein receptor 
(LDLR) family, are the most common co-receptors for Fzs (Figure 1.1, Wehrli et al., 
2000; Tamai et al., 2000). We know a great deal more about the role of LRPs in the 
activation of cytoplasmic Wnt signaling than we do about the role of Fzs. LRP5/6 are 
single-pass transmembrane receptors with an intracellular domain that provides binding 
sites for Wnt effectors. Wnt stimulation drives the phosphorylation of five intracellular 
PPPSPxS repeats by the kinases CK1a and GSK-3a/b (Davidson et al., 2005). These 
phosphorylated motifs serve as binding sites for the scaffold protein Axin, whose 
membrane association releases the negative regulation of the transcriptional co-activator 
b-catenin (discussed further in Section 1.3) (Tamai et al., 2004) (Zeng et al., 2005) 
(Davidson et al., 2005).  
How do Wnts engage LRPs? The field has yet to produce a crystal structure of a 
Wnt bound to an LRP, but both biochemical and cellular studies suggest that LRPs may 
have multiple Wnt binding sites. The extracellular domains of LRPs include four tandem 
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copies of a motif containing a b-propeller domain followed by an EGF repeat 
(MacDonald and He, 2012). Antibodies targeting the first (N-terminal) b-propeller domain 
of LRP6 block the signaling activity of most Wnts (1, 2, 2b, 6, 7a, 7b, 8a, 9a, 9b, 10a, 
10b), with the exception of Wnts 3 and 3a (Gong et al., 2010; Ettenberg et al., 2010). In 
converse, antibodies recognizing the third b-propeller domain selectively inhibit Wnt3/3a 
signaling.  Biochemical data suggests that LRPs may engage these two Wnt-binding 
sites concurrently, with the prediction that LRPs may form oligomers containing multiple 
Fzs and Wnts at the cell surface (Bourhis et al., 2010). However, the mechanisms by 
which Wnts recognize, and distinguish between, these two sites remain unknown.  
Recently, both genetic and cellular data have come to support the role of 
receptor tyrosine kinases (RTKs) as alternative Wnt receptors. RTKs differ from Fzs and 
LRPs in that, even amongst those that play a role in Wnt signaling, they contain diverse 
extracellular domains (Lemmon and Schlessinger, 2010). Some RTKs, including Ror2 
and MuSK, contain CRDs that are related by both structure and function to Fz CRDs 
(Lemmon, unpublished; Saldanha et al., 1998; Oishi et al., 2003; Jing et al., 2009; 
Strochlic et al., 2012). However, unlike Fzs, the CRDs of RTKs form only part of a 
complex extracellular architecture that includes Ig domains and other domains of 
unknown function. PTK7 (or CCK4) is another Wnt-binding member of the RTK family 
that contains only Ig domains in its extracellular region, suggesting that Ig domains may 
also be capable of direct binding to Wnts (Lu et al., 2004b; Yen et al., 2009; Peradziryi et 
al., 2011; Martinez et al., 2015). Ryk is an RTK that contains an extracellular Wnt-
inhibitory factor (WIF) domain similar to the WIF family of secreted Wnt antagonists and 
binds Wnt ligands directly (Patthy, 2000; Lemmon, unpublished).  
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In the canonical view of RTK signaling, ligand-induced receptor dimerization 
releases autoinhibition of the intracellular kinase domains by phosphorylation in trans 
(Lemmon and Schlessinger, 2010). However, Wnt-binding RTKs seem to break the 
canon, as Ror2, PTK7, and Ryk are all pseudokinases (Murphy et al., 2014; Mendrola et 
al., 2013; Yoshikawa et al., 2001; Inoue et al., 2004). Although we do not yet understand 
the nature of the Wnt-dependent complexes formed by RTKs, these receptors may 
undergo homodimerization (Liu et al., 2007; Liu et al., 2008; Grumolato et al., 2010), 
heterodimerization (Martinez et al., 2015), or act as alternative co-receptors for Fzs 
(Oishi et al., 2003; Yamamoto et al., 2008; Lu et al., 2004a; Kim et al., 2008; Shnitsar 
and Borchers, 2008). In summary, these data suggest that Wnts may recognize a 
diverse array of receptor domains, including CRDs, b-propeller domains, Ig domains and 
WIF domains. However, we know very little about what structural features of Wnts are 
required for these receptor interactions. The goal of this thesis to contribute to our 
understanding of how Wnts recognize binding partners in vivo.  
 
1.2. Wnts activate at least two intracellular signaling pathways 
1.2.1. The b-catenin dependent pathway 
The best-studied role of Wnt signaling is to regulate the stability of the transcriptional co-
activator b-catenin. Under basal conditions, intracellular levels of b-catenin are kept low 
by the activity of a large molecular machine called the b-catenin destruction complex 
(Figure 1.2, Nusse and Clevers, 2017). The core of the destruction complex is 
composed of two regulatory proteins, Axin and the APC tumor suppressor, that scaffold 
interactions between b-catenin and the serine/threonine kinases CK1a and GSK3a/b 
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(Liu et al., 2002; Amit et al., 2002; Munemitsu et al., 1995; Behrens et al., 1998; Hart et 
al., 1998; Nakamura et al., 1998; Hinoi et al., 2000). Sequential phosphorylation of b-
catenin by these two kinases, respectively, creates a phosphodegron that targets b-
catenin to the proteasome (Liu et al., 2002; Amit et al., 2002).  
Wnt binding to Fz and LRP5/6 at the cell surface increases the stability of 
cytoplasmic b-catenin (Figure 1.2, Cook et al., 1996; Hernández et al., 2012), which can 
then translocate into the nucleus and act as a transcriptional co-activator with the 
TCF/LEF family of transcription factors (Behrens et al., 1996; Molenaar et al., 1996; 
McKendry et al., 1997; Brunner et al., 1997). A recent kinetic study of the CK1a and 
GSK3a/b phosphosites on b-catenin provided strong evidence that Wnt binding at the 
cell surface influences b-catenin stabilization at or upstream of b-catenin 
phosphorylation, although the mechanistic explanation for these observations remains 
contentious (Hernández et al., 2012). Data from the Klein laboratory supports the 
hypothesis that the kinase activity of GSK3a/b is enhanced by association with APC 
within the destruction complex under basal conditions (Valvezan et al., 2012). Upon Wnt 
stimulation, Axin translocates to the membrane and binds the phosphorylated tail of 
LRP5/6 (Mao et al., 2001; Tamai et al., 2004), causing a conformational change which 
dissociates APC from the destruction complex and decreases the activity of GSK3a/b 
towards b-catenin (Valvezan et al., 2012; Tran and Polakis, 2012).  
What is the role of Fz and Dishevelled in this process? The binding of 
Dishevelled to the intracellular domain of Fzs appears to be critical for the activation of 
the canonical pathway but its mechanism of action is not clear (Nusse and Clevers, 
2017). A recent study observed interactions between the DIX domains of Dishevelled 
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and Axin by NMR spectroscopy, suggesting that the binding of these two proteins at the 
membrane could play a role in stabilizing the active receptor complex and maintaining 
the interaction between Axin and LRP5/6 (Fiedler et al., 2011). 
The stoichiometry of Wnt-induced complexes containing both Fzs and LRP5/6 is 
also not yet clearly defined. Although it is assumed to contain a 1:1:1 ratio of ligand to 
receptors, LRPs contain multiple Wnt binding sites that might be occupied 
simultaneously (Bourhis et al., 2010), allowing a single co-receptor to stabilize many 
Wnt/Fz pairs. Furthermore, ligands structurally unrelated to Wnts, such as Norrin, bind 
Fzs with distinct stoichiometry. Norrin is a lipid-free ligand for Fz4 that binds to the first 
and second b-propeller domains of LRP6 and activates the canonical Wnt pathway 
during angiogenesis in the developing eye (Xu et al., 2004; Ke et al., 2013; Shen et al., 
2015; Chang et al., 2015). Unlike Wnts, Norrin is a dimer that can engage multiple Fz4 
CRDs simultaneously, arguing that Fz clustering may be important to forming an active 
signaling complex (Shen et al., 2015; Chang et al., 2015). In summary, although Fz and 
LRP5/6 heterodimers are sufficient to activate Wnt signaling, the endogenous 
complexes formed at the cell membrane may be large assemblies of many Wnts and 
Wnt receptors.  
Another unresolved aspect of the Fz and LRP5/6 complex is how Wnt binding 
regulates the active conformations of these receptors. Chimeric ligands that link lipid-
free Fz-binding and LRP-binding modules can activate canonical Wnt signaling in vivo 
(Janda et al., 2017; Yan et al., 2017). Therefore, bringing the two receptors into close 
proximity may be sufficient to activate intracellular signaling. Additionally, a recent crystal 
structure of full-length Smoothened, a Hedgehog pathway receptor closely related to 
Fzs, suggests that conformational coupling between the ligand-binding module and the 
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intracellular motifs may be important for adopting the active signaling conformation of 
this class of receptors (Byrne et al., 2016). Although the purification and crystallization of 
Wnt/receptor complexes has proven difficult, structural studies performed with these 
new, chimeric ligands may yield insights into the conformation changes at the level of 
the receptor that induce active Wnt signaling.  
 The earliest evolutionary function of b-catenin dependent Wnt signaling was to 
provide a mechanism for patterning the the multicelluar embryo (Holstein, 2012). Key 
proteins in the pathway, including Wnts, Fzs, APC, and Axin, are absent from the 
genomes of protozoans but appear in primitive metazoans (Guder et al., 2006). b-
catenin dependent signaling is responsible for establishing the anterior-posterior, or 
primary, body axis of almost all extant bilaterian and non-bilaterian metazoans (Petersen 
and Reddien, 2009a). These data demonstrate that specification of the primary body 
axis by b-catenin dependent Wnt signaling is a unifying principle of multicellular 
development.  
Regeneration studies in planarians have proven to be an excellent system to 
study the conserved mechanisms of axis polarity. Transverse bisection of planaria 
initiates the regeneration of both anterior and posterior structures in the two resulting 
organisms. The treatment of regenerating planaria with siRNA targeting b-catenin or Wnt 
(WntP-1) results in the regeneration of only anterior structure (Petersen and Reddien, 
2008; Gurley et al., 2008; Petersen and Reddien, 2009b). In contrast, siRNA knockdown 
of APC results in the regeneration of only posterior structures (Gurley et al., 2008). 
These data suggest that the patterning of the posterior pole requires high levels of Wnt 
signaling whereas the anterior pole requires low Wnt signaling. Indeed, the formation of 
8	
	
a posterior-high to anterior-low (or no) Wnt gradient is the conserved mechanism of 
establishing axis polarity from cnidarians to mammals (Petersen and Reddien, 2009a). 
In both frogs and fish, the b-catenin dependent pathway also plays an important 
role in patterning the dorsal-ventral axis. Shortly after fertilization, frog embryos undergo 
a mechanical rearrangement during which the cell cortex shifts 30o relative to the 
cytoplasm (Vincent et al., 1986). This rotation brings Wnt11 (Tao et al., 2005), originally 
associated with the vegetal cortical cytoplasm, in contact with the equatorial band of 
mesoderm on one side of the embryo (Rowning et al., 1997). Focal activation of the b-
catenin dependent pathway within the mesoderm induces the transcription of dorsal 
determinants, includng Siamois and Xnr3 (Lemaire et al., 1995; Brannon and Kimelman, 
1996; Kessler, 1997; Smith et al., 1995; McKendry et al., 1997; Fan and Sokol, 1997). 
These cells give rise to the dorsal organizing center, originally identified by Hans 
Spemann and Hilde Mangold, which is necessary and sufficient for dorsalizing the three 
germ layers of the embryo (De Robertis et al., 2000).  
The examples illustrated here represent only a small fraction of the patterning 
events that Wnts control during development. Murine knockout studies of components of 
the b-catenin dependent pathway show many tissue- and organ-specific defects (Logan 
and Nusse, 2004). One of the overarching themes that arises from these studies, 
however, is that the b-catenin dependent pathway is a master regulator of cell identity, 
survival and proliferation.  
 The b-catenin dependent pathway also plays important roles in adult tissue 
homeostasis and disease. Wnt signals are critical for the maintenance of stem cell 
identity in blood (Willert et al., 2003; Huang et al., 2012), skin (Lim et al., 2013), small 
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intestine (Korinek et al., 1998), and many other organs. Furthermore, Wnt stimulation 
has also proven critical to the culture of organoids derived from these tissues (Nusse 
and Clevers, 2017).  
Unsurprisingly, the misregulation of this pro-proliferative, pro-survival signaling 
pathway often leads to human disease. Mammalian Wnt genes were first discovered as 
a common site of proviral insertion for the mouse mammary tumor virus (Nusse and 
Varmus, 1982). The most frequent disease-causing mutations in the pathway occur at 
the level of the b-catenin destruction complex, particularly APC (Anastas and Moon, 
2012). Patients heterozygous for a loss-of-function allele of APC develop familial 
adenomatous polyposis, a disease characterized by the development of many hundreds 
of non-cancerous polyps throughout the intestine. With loss of heterozygosity, these 
polyps progress to colon cancer (Kinzler and Vogelstein, 1996). More recently, it was 
discovered that Wnt expression becomes upregulated in various human cancers, 
making them a potentially valuable therapeutic target (Yu et al., 2012; Madan et al., 
2016; Tammela et al., 2017). However, the field lacks the mechanistic understanding of 
the interactions between Wnts and their respective receptors that might be used for the 
design of targeted therapeutics.  
 
1.2.2. The planar cell polarity pathway 
The planar cell polarity (PCP) pathway is a signaling cascade that induces the 
synchronized polarity of cells across the surface of a developing tissue. Our 
understanding of what this polarity looks like, with regards to both the composition and 
the asymmetric distribution of receptor complexes across a cell, originates from studies 
10	
	
of the Drosophila wing epithelium. In this tissue, the PCP pathway polarizes the apical 
surface of the epithelial cell layer to orient the uniform directional growth of wing hairs. 
The pathway consists of a core set of effectors that include both transmembrane (e.g., 
Fz/Fz1, Van Gogh/Strabismus, Flamingo) and intracellular (e.g., Dishevelled, Prickle, 
Diego) proteins (Gray et al., 2011). When a polarity signal is sensed by cells, the 
effectors are redistributed in an asymmetric fashion so that Van Gogh/Prickle complexes 
associate with the proximal apical membrane and Fz/Dishevelled/Diego complexes 
associate with the distal (Gray et al., 2011). PCP signaling also activates the small 
GTPase Rho and the Rho-associated kinase (ROK). The downstream consequences of 
activating these proteins have not been clearly elucidated in this system, but they likely 
play an important role in cytoskeletal remodeling and the establishment of cytoskeletal 
polarity (Amano et al., 2010).   
Although Wnts are predicted to provide a polarity cue that initiates PCP signaling 
across a tissue, evidence for their involvement in Drosophila PCP remains limited. A 
recent study used both loss-of-function and gain-of-function analysis to suggest that 
gradients of Wingless (Wg, Drosophila homolog of Wnt1) and Wnt4 may bind Fz and 
provide directional cues for hair cell orientation in the Drosophila wing imaginal disc (Wu 
et al., 2013). However, the b-catenin dependent pathway and PCP pathway often work 
in tandem, first to establish cell identity and subsequently to induce cell polarity (Swarup 
and Verheyen, 2012), and therefore separating the contributions of these two pathways 
to tissue patterning has made interpretation of PCP phenotypes difficult. Furthermore, 
Wnt/Fz complexes activating the PCP pathway are thought to be LRP5/6 independent 
(van Amerongen and Nusse, 2009) and the question of which (if any) co-receptor 
stabilizes these interactions remains one of the key unanswered questions in the field.  
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 The vertebrate planar cell polarity pathway appears to be a far more complicated 
signaling system, both requiring the core components identified in Drosophila as well as 
a much wider variety of Wnt receptors (Kikuchi et al., 2009). The polarization of the hair 
bundles on vestibular sensory cells within the mammalian inner ear has become a model 
system for studying the components of vertebrate PCP signaling. Mice null for both Fz3 
and Fz6 display a pronounced misorientation of hair sensory cells, phenotypes 
analogous to the disruptions of polarity caused by Fz loss-of-function in the Drosophila 
wing (Wang et al., 2006b; Gubb and García-Bellido, 1982). Knockouts of Ryk, Ror2 and 
PTK7 all display similar defects in sensory cell polarity (Andre et al., 2012; Yamamoto et 
al., 2008; Lu et al., 2004b), suggesting that multiple types of Wnt-dependent receptor 
complexes may drive vertebrate PCP signaling (Figure 1.3). Genetic studies in zebrafish 
provide clear evidence that Wnts 5a and 11 control vertebrate PCP signaling 
(Heisenberg et al., 2000; Kilian et al., 2003). However, we do not yet understand what 
types of complexes assemble or how Wnt signals control their polarity.   
 Planar cell polarity signaling contributes to many tissue patterning events during 
embryogenesis. In vertebrates, the PCP pathway shapes at least two distinct types of 
morphological outcomes. The first outcome, as seen in the patterning of the hair cells of 
the inner ear, is to establish an architectural symmetry across the surface of a tissue. 
The second outcome is to link cell polarity with directed cell migration and/or cell 
rearrangement. The best-studied example of this patterning is the control of convergent 
extension movements in gastrulating frog and fish embryos (Skoglund and Keller, 2010). 
Convergent extension is a series of coordinated cellular rearrangements that result in 
the thinning and elongation of the tissues of the dorsal mesoderm and neuroectoderm 
(Keller and Tibbetts, 1989; Keller et al., 1989; Wallingford et al., 2000; Smith et al., 
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2000). The cells within these tissues must be synchronously polarized for this 
rearrangement to occur correctly, and overexpression or depletion of PCP components 
results in neural tube closure defects and a shortened, curved axis (Sokol, 1996; 
Deardorff et al., 1998; Djiane et al., 2000; Wallingford et al., 2000; Smith et al., 2000; 
Wallingford et al., 2002). The role of PCP signaling in convergent extension movements 
is conserved in mammals (Wang et al., 2006a; Mahaffey et al., 2013) and disruption of 
this pathway similarly results in defects in neural tube closure in mice (Hamblet et al., 
2002; Wang et al., 2006b; Etheridge et al., 2008; Yamamoto et al., 2008; Lu et al., 
2004b). Genetic knockouts of PCP pathway components also show phenotypes in other 
morphogenic processes, most notably in cardiogenesis and limb bud elongation 
(Hamblet et al., 2002; Oishi et al., 2003; Halford et al., 2000).  
 Specific components of the PCP pathway have been implicated in both human 
congenital disorders and cancer phenotypes. Vangl1/2 (mammalian homolog of 
Strabismus) mutations were identified in a small subset of patients with neural tube 
defects (Kibar et al., 2007). Loss-of-function mutations in Ror2, Wnt5a and Dishevelled1 
cause both dominant and recessive forms of Robinow Syndrome, a congenital dwarfism 
(van Bokhoven et al., 2000; Afzal et al., 2000; Person et al., 2010; White et al., 2015). 
Ror2 signaling through Wnt5a also appears to contribute to the invasive phenotypes of 
many metastatic cancers (Enomoto et al., 2009; O'Connell et al., 2010; Yamamoto et al., 
2009). Ror2 may prove to be an effective therapeutic target due to its low expression in 
adult tissues (Oishi et al., 1999), but to date, its mechanism of activation remains poorly 
understood.  
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1.2.3. Structural determinants of pathway specificity 
Early studies searched for a one-to-one code of Wnts and Fzs whose relative expression 
would determine cell responsiveness and pathway activation. However, in cell-based 
assays, Wnts bind Fzs with highly-overlapping affinities (Hsieh et al., 1999; Deardorff et 
al., 2001; Ring et al., 2014; Dijksterhuis et al., 2015). The perceived promiscuity of Wnts 
has led to the hypothesis that selective pathway activation may be entirely determined 
by the cohort of receptors expressed by a given cell (Mikels and Nusse, 2006; He et al., 
1997; Umbhauer et al., 2000). In support of this argument, Fz/Fz1 and Fz2 in Drosophila 
demonstrate structurally-encoded signaling specificity: although both receptors are 
capable of binding Wg (Rulifson et al., 2000), ectopic expression of either Fz1 or Fz2 in 
the wing imaginal disc of the Drosophila embryo causes strikingly different phenotypes. 
Whereas Fz1 overexpression disrupts PCP-dependent hair cell polarity (Krasnow and 
Adler, 1994; Boutros et al., 2000), Fz2 causes the formation of ectopic hairs by 
activating b-catenin dependent signaling (Cadigan et al., 1998; Zhang and Carthew, 
1998). Through the use of Fz1/2 chimeras, researchers determined that the C-tail and 
intracellular loops of the transmembrane domain strongly influence the type of signaling 
response occurring downstream of a receptor (Boutros et al., 2000). In vertebrates, Fzs 
3, 6 and 7 specifically signal through the PCP pathway (Gray et al., 2011), arguing that 
pathway selectivity is a highly-conserved, receptor-intrinsic property. 
 However, it seems undeniable that Wnts also contribute to signaling specificity. 
Similar to the functional differences observed between Drosophila Fzs 1 and 2, ectopic 
expression of Wnts in Xenopus embryos causes different phenotypic consequences. 
During the developmental window when the Xenopus dorsal-ventral axis is specified, the 
cells of the mesoderm remain competent to respond to the b-catenin dependent pathway 
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during cleavage stages (Heasman et al., 2000; Kao et al., 1986). A small subset of those 
cells is exposed to Wnt11 through the process of cortical rotation and becomes fated to 
form the dorsal organizing center (De Robertis et al., 2000). Ectopic expression of Wnts, 
or other positive regulators of b-catenin stability, within the naïve mesoderm induces the 
formation of a second organizing center (McMahon and Moon, 1989; Sokol et al., 1991; 
Funayama et al., 1995; Molenaar et al., 1996). These embryos develop two complete 
dorsal-anterior axes, including head, notochord, somites, and neural tube (Sokol et al., 
1991).  
However, only a subclass of Wnt ligands, including Wnts 1, 3a and 8, are 
capable of inducing axis duplication (McMahon and Moon, 1989; Sokol et al., 1991). The 
other subclass, which includes Wnt5a and Wnt4, does not readily induce second axes 
but can disrupt PCP-dependent convergence and extension movements when 
expressed from the dorsal tissues of the embryo (Du et al., 1995). Wnt11 appears to be 
a special case, as it is capable of inducing both phenotypes (Tao et al., 2005; Du et al., 
1995). These data argue that Wnts have fundamentally different affinities for the Fzs (7 
and 4), or Fz co-receptors, that are expressed in the Xenopus embryo during this 
developmental window (Medina et al., 2000; Shi and Boucaut, 2000). Furthermore, they 
demonstrate that the unique affinities of Wnts for receptors plays an important role in 
selective pathway activation.  
 Wnts engage a wide variety of receptors to regulate the activation of at least two 
distinct signaling outcomes in vivo. New research in the field continues to identify novel 
ways these complexes can be modified, such as through the regulation of Fz stability at 
the cell membrane by R-spondin signaling (Nusse and Clevers, 2017). However, our 
incomplete understanding of the core mechanisms by which Wnts control the formation 
15	
	
of different types of receptor complexes limits our interpretations of these novel pathway 
regulators. This thesis aims to address this gap in our knowledge by investigating the 
structural requirements for Wnt binding to receptors in vivo. 
 
1.3. Receptor recognition by Wnts 
One of the most important, and unanswered, questions in Wnt signaling is how Wnts 
recognize and engage different cell surface receptors. Our understanding of the 
biochemistry of Wnts and Wnt receptors has been stymied by technical difficulties 
associated with purifying and analyzing these ligands in vitro. Wnts are structurally 
complex proteins, sharing a nearly-invariant pattern of 22 cysteine residues that form 11 
disulfide bonds (Janda et al., 2012). The polypeptide chain of Wnts also undergoes 
significant post-translational modification, including high levels of asparagine 
glycosylation (Komekado et al., 2007; Tanaka et al., 2002; Kurayoshi et al., 2007). 
Furthermore, most Wnts are post-translationally acylated at a highly-conserved serine 
residue (Willert et al., 2003; Takada et al., 2006; Kurayoshi et al., 2007; Najdi et al., 
2012). The only exceptions to this rule are WntD (Ching et al., 2008) and DWnt5 
(Lemmon lab, unpublished), both found in Drosophila.  
Wnts are acylated by Porcupine, a membrane-bound O-acyltransferase. This 
hypothesis is primarily supported by in vivo data demonstrating that Porcupine inhibition 
or knockdown can reduce the hydrophobicity of Wnts, impair their secretion, and reduce 
their function (Zhai et al., 2004; Galli et al., 2007; Chen et al., 2009; van den Heuvel et 
al., 1993; Proffitt and Virshup, 2012; van den Heuvel et al., 1993; Chen et al., 2009; 
Biechele et al., 2013; Proffitt and Virshup, 2012). More recent biochemical data provides 
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support to the argument that Porcupine directly facilitates the chemical transfer of a fatty 
acid moiety to Wnt proteins (Takada et al., 2006; Gao and Hannoush, 2014; Rios-
Esteves and Resh, 2013). The fatty acid itself is likely monounsaturated and between 
13-16 carbons in length (Takada et al., 2006; Rios-Esteves and Resh, 2013) (Gao and 
Hannoush, 2014; Janda et al., 2012). Due to this modification, Wnts require detergents 
for solubilization in vitro, making them incompatible with many of the biochemical assays 
that might be used to determine the mechanisms of Wnt/receptor interactions (Willert et 
al., 2003; Kurayoshi et al., 2007). 
Our current biochemical understanding of receptor recognition by Wnts is derived 
from a single crystal structure depicting xWnt8 bound to the mFz8 CRD (Janda et al., 
2012). In this structure, xWnt8 adopts a crescent-like shape and engages the CRD with 
its extended arms, resembling the shape of a hand delicately grabbing an object with its 
thumb and index finger (Figure 1.4). The “thumb” represents the N-terminal arm of the 
Wnt, which interacts with the CRD at a surface called Site 1. The acylated serine sits at 
the tip of the thumb, and binding of the acyl group of the Wnt to a hydrophobic groove on 
the side of the CRD provides the primary driving force for Site 1 interaction (Janda et al., 
2012). As all vertebrate Wnts are acylated at an equivalent residue, this binding mode 
may serve as a common mechanism for CRD recognition. However, this hypothesis has 
yet to be directly tested. The second crystallographic interface occurs almost 180o away 
from Site 1, where the C-terminal “index finger” of the Wnt binds to the CRD through a 
protein-protein interface. This interface, called Site 2, is primarily stabilized by 
hydrophobic contacts between the two proteins. The amino acids on xWnt8 that engage 
in the Site 1 and Site 2 interactions are highly conserved across the Wnt family, 
strengthening the argument that they are likely to be bona fide binding interfaces in vivo 
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(Janda et al., 2012). Nevertheless, it is important to validate the biological predictions of 
a crystal structure to ensure that the interfaces do not represent a kinetically-trapped 
interaction or a binding intermediate. These assays have not been performed in the case 
of the xWnt8/mFz8 CRD structure. Therefore, while structure provides a useful starting 
point for our understanding of how Wnts bind CRDs, it also raises many questions about 
the nature of Wnt/receptor interactions in vivo.  
 
1.4. The role of acylation in Wnt signaling 
The xWnt8/mFz8 CRD crystal structure played an important role in resolving a decade-
long controversy surrounding the site of acylation on Wnts. In 2003, the first study to 
report Wnt acylation used mass-spectrometry to identify the modified amino acid as the 
most N-terminal cysteine reside of Wnt3a (Willert et al., 2003). Many studies aiming to 
understand the role of acylation in Wnt signaling analyzed how mutations at this cysteine 
(also conserved across the Wnt family) changed the biological activity of Wnts (Willert et 
al., 2003; Komekado et al., 2007; Galli et al., 2007; Kurayoshi et al., 2007; Franch-Marro 
et al., 2008; Bänziger et al., 2006; Mulligan et al., 2012). However, a subsequent mass-
spectrometry analysis of the same protein identified an alternative site of acylation at a 
serine residue (Takada et al., 2006) and the xWnt8/mFz8 CRD crystal structure has 
confirmed that this residue is the only site where covalent attachment of the acyl chain 
occurs (Janda et al., 2012). The previously implicated cysteine is, in fact, involved in a 
disulfide bond, suggesting that phenotypes caused by mutation of this cysteine, and 
attributed to acylation defects, were likely caused by protein misfolding. Thus, while the 
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crystal structure provided valuable information about the site of acylation, it also 
reopened many questions surrounding the role of acylation in Wnt signaling in vivo. 
Acylation likely plays multiple roles in the signaling of Wnts. First, acylation 
appears to be required for the association of Wnts with Evi/Wntless, a cargo receptor 
that facilitates the trafficking of Wnts through the secretory pathway in many organisms 
(Bartscherer and Boutros, 2008). Second, acylation helps to shape extracellular Wnt 
gradients. Historically, Wnts were predicted to pattern tissues in the concentration-
dependent manner of classic morphogens. The patterning of the Drosophila wing 
imaginal disc by Wg was the prototypical example of long-range Wnt signaling. In this 
tissue, Wnt-responsive genes senseless (high concentration threshold), distal-less 
(moderate concentration threshold) and vestigial (low concentration threshold) are 
activated at a distance from Wg-expressing cells (Lecuit and Cohen, 1997; Neumann 
and Cohen, 1997; Zecca et al., 1996; Swarup and Verheyen, 2012). However, it was 
recently demonstrated that a membrane-tethered version of Wg (NRT-Wg) can rescue 
Wg mutant embryos, suggesting that Wg gradients form through mechanisms 
independent of ligand diffusion (Alexandre et al., 2014). It is now well-accepted that, in 
most physiological contexts, Wnts signal by local cell-to-cell mechanisms (Papkoff and 
Schryver, 1990; Willert et al., 2003; Gao et al., 2011; Pfeiffer et al., 2002; Franch-Marro 
et al., 2008; Galli et al., 2007; Farin et al., 2016; Alexandre et al., 2014). The 
hydrophobic quality of the acyl tail may therefore “tether” Wnts to cell membranes in 
order to restrict their diffusion (Bartscherer and Boutros, 2008). Acylation also plays a 
tethering role in the biological activity of the EGFR ligand, Spitz (Miura et al., 2006). 
Lastly, the crystal structure of xWnt8 bound to the CRD of mFz8 predicts that acylation is 
required for Wnt recognition of Fzs at the cell surface (Janda et al., 2012). Based on this 
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evidence, there is a reasonable assumption in the field that Wnts require acylation for 
their biological activity. However, this prediction has not been systematically tested.  
 
1.5. Research summary 
This work directly examines the role of acylation in the in vivo signaling of Wnts. I began 
by analyzing the contributions of the Site 1 and Site 2 interfaces, predicted by the 
xWnt8/mFz8 CRD crystal structure, to the biological activity of xWnt8. I hypothesized 
that if these interfaces were critical for the ability of xWnt8 to engage CRDs, then 
mutating key amino acids at these sites would abolish the signaling of xWnt8 in vivo. 
xWnt8 is a potent activator of the b-catenin dependent pathway (Sokol et al., 1991). 
Therefore, I tested the signaling activity of xWnt8 mutants by evaluating their ability to 
cause dorsalization phenotypes in Xenopus embryos and to activate the transcription of 
the Wnt-responsive genes Siamois and Xnr3. I show that introducing point mutations to 
the predicted Site 2 interface abolishes the signaling of xWnt8 in Xenopus embryos. In 
contrast, mutating Site 1, including the acylated serine residue on xWnt8 (S187A), only 
caused a mild attenuation in signaling. These data suggested that xWnt8 might be 
capable of acylation-independent signaling. If true, I predicted that xWnt8 S187A would 
be capable of binding to Fz CRDs in vivo. To test this, I measured the association of 
xWnt8 S187A with the CRD of xFz8 by immunoprecipitation. I found that xWnt8 S187A 
was able to interact with the xFz8 CRD, providing support to the argument that acylation 
is not absolutely required for the signaling of xWnt8 in vivo. The data from these 
experiments are presented in Chapter 2.  
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 In Chapter 3, I next asked whether other members of the Wnt family were also 
capable of acylation-independent signaling. I began these studies by analyzing the role 
of acylation in the signaling of Wnts 1 and 3a, which also activate the b-catenin 
dependent pathway and are considered functionally redundant with Wnt8. I mutated the 
respective sites of acylation on both Wnts and measured their ability to dorsalize 
Xenopus embryos and activate the transcription of Siamois and Xnr3. I discovered that 
Wnt3a, like xWnt8, can activate the b-catenin dependent pathway when acylation is 
prevented. In contrast, Wnt1 demonstrated no acylation-independent activity. Finally, I 
tested the role of acylation in the signaling of Wnt5a, a ligand that preferentially activates 
the planar cell polarity pathway. I discovered that Wnt5a, like Wnt 1, does not induce 
PCP dependent phenotypes in embryos when acylation is prevented. These data argue 
that neither acylation-dependence nor acylation-independence is a unique property of 
the Wnt family. Further a discussion of the implications of this work, with an emphasis on 
how these results affect our understanding of the structural relationships between Wnts 
and their receptors, is presented in Chapter 4.  
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Figure 1.1. Wnts bind a diverse set of cell surface receptors. 
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Figure 1.1. Wnts bind a diverse set of cell surface receptors. All Wnts bind the 
Frizzled (Fz) family of seven-pass transmembrane receptor (left) at their cysteine-rich 
domain (CRD). LRP5/6 (second left) act as co-receptors for Fzs. The LRP5/6 
extracellular domain is composed of repeating β-propeller and EGF repeat  elements. 
The first (top) and third β-propeller domains are thought to contain Wnt binding sites.  
Members of the receptor tyrosine kinase family, all containing intracellular kinase 
domains, may also act as Wnt receptors. Ror2 and MuSK also contain a CRD important 
for Wnt binding. Ror2 also has an extracellular Ig domain  and Kringle domain of 
unknown function. MuSK contains two additional Ig domains in addition to the CRD. 
PTK7 (also known as CCK4) has seven tandem Ig domains in its extracellular domain. 
Ryk contains an extracellular Wnt-inhibitory factor (WIF) domain homologous to the WIF 
family of secreted Wnt antagonists. 
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Figure 1.2. The β-catenin dependent pathway. 
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Figure 1.2 The β-catenin dependent pathway. (A) In the absence of Wnt, β-catenin 
levels are kept low by the β-catenin destruction complex, composed of Axin, APC, CK1α 
and GS3Kα/β. Sequential phosphorylation of β-catenin by CK1α and GS3Kα/β marks it 
for proteasomal degradation. (B) Upon Wnt binding to a Fz and LRP5/6 heterodimer at 
the cell surface, CK1α and GS3Kα/β phosphorylate PPPSPxS repeats on the 
intracellular domain of LRP5/6. Axin binds these phosphorylated motifs on LRP5/6, 
which induces the dissociation of APC from the complex. Dishevelled binds the 
intracellular C-tail of Fz and may also bind Axin. Without APC, the kinase activity of 
GS3Kα/β is reduced, and less β-catenin is marked for destruction. β-catenin is then able 
to translocate into the nucleus and bind to the TCF/LEF family of transcription factors to 
activate the transcription of target genes. 
  
25	
	
Figure 1.3. The Planar Cell Polarity pathway. 
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Figure 1.3. The Planar Cell Polarity pathway. The Planar Cell Polarity (PCP) pathway 
creates synchronized polarity across the surface of a tissue through the asymmetric 
redistribution of receptor complexes. In vertebrates, PCP signaling is activated by Wnts 
5a and 11 through their interaction with a wide variety of cell surface receptors. Genetic 
evidence suggests Fzs, Ror2, Ryk, MuSK and PTK7 likely play a role in controlling 
polarity. However, how these receptors engage Wnts, and what types of complexes 
form, remain poorly understood. The pathway depends upon the intracellular effectors 
Dishevelled, the small GTPase Rho and the Rho-associated Kinase (ROK), and the 
kinase JNK. Current evidence points to these effectors having complex, cell type specific 
mechanisms of action.  
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Figure 1.4. The xWnt8/mFz8 CRD crystal structure.  
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Figure 1.4. The xWnt8/mFz8 CRD crystal structure. Crystal structure of xWnt8 
(green) bound to the mFz8 CRD (black) (PDB ID: 4F0A). The “thumb” and “index finger” 
arms of xWnt8 bind the CRD at interfaces Site 1 (red) and Site 2 (blue), respectively. 
The covalently attached palmitoleate moeity (red), also referred to as the “acyl tail,” on 
xWnt8 is the primary driver of Site 1 binding.  
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Chapter 2: Acylation in xWnt8 signaling 
2.1 Introduction 
Wnts are a family of 19 unique ligands that play key roles in the patterning and 
maintenance of the vertebrate organism. Wnt signaling regulates cell fate, proliferation, 
survival, polarity and migration under different physiological contexts (Kikuchi et al., 
2009). The remarkable capacity for these ligands to control such a highly diverse set of 
cell processes is tied to their ability to engage and regulate many classes of cell surface 
receptor (Niehrs, 2012). However, the mechanisms by which Wnts recognize these 
receptors largely remains a mystery.  
 Binding studies using chimeric ligands have provided evidence that Wnts are 
multivalent proteins that crosslink a CRD-containing receptor to a co-receptor (Cong et 
al., 2004; Holmen et al., 2002; Janda et al., 2017). Most Wnt signaling occurs through 
the CRDs of Fzs, but members of the RTK family, including Ror2 and MuSK, also 
contain CRDs that are likely to be important for Wnt binding (Niehrs, 2012). Biochemical 
investigations into the interactions between Wnts and CRDs have been limited by 
technical difficulties associated with purifying active Wnt protein. Wnts are post-
translationally acylated at a highly-conserved serine residue by the enzyme Porcupine 
(Willert et al., 2003; Takada et al., 2006; Gao and Hannoush, 2014). Unfortunately, the 
detergents required to stabilize this hydrophobic modification in vitro are incompatible 
with many of the biochemical assays that have been used to elucidate the binding 
mechanisms of other receptor and ligand families.  
Our current understanding of the interactions of Wnts with CRDs is derived from 
a single crystal structure depicting the interaction of xWnt8 with the CRD of mFz8 ( 
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Janda et al., 2012). In this structure, xWnt8 adopts a crescent-like shape and engages 
the CRD with two long projections called the thumb and index finger at interfaces named 
Site 1 and Site 2, respectively (Fig 1.4). The acylated serine residue on xWnt8 lies at the 
tip of the thumb, and the sequestration of this hydrophobic moiety within a binding 
groove on the side of the CRD is the primary driving force for the Site 1 interaction. At 
Site 2, which lies on the opposite side of the CRD, the index finger of xWnt8 engages 
the CRD primarily through a series of hydrophobic protein-protein contacts (Fig 1.4). The 
structural evidence presented in the xWnt8/mFz8 CRD crystal structure has led to the 
hypothesis that Wnts require acylation to recognize receptors. By extension, these data 
predict that a non-acylated Wnt will lack biologically activity. However, the interfaces 
engaged by xWnt8 in the crystal structure remain unverified in vivo, raising the possibility 
that they may not accurately represent the Wnt/CRD interactions occurring at the cell 
surface.  
To determine the role of acylation in CRD binding, we assessed the relevance of 
the crystallographic Site 1 and Site 2 interfaces to the biological activity of xWnt8. 
Ectopic Wnt expression in the early Xenopus embryo causes the activation of the b-
catenin dependent pathway, the formation of a second dorsal organizing center and the 
subsequent development of twinned dorsal structures (De Robertis et al., 2000; 
McMahon and Moon, 1989; Sokol et al., 1991). We hypothesized that introducing 
mutations to the protein surfaces required for CRD recognition would inhibit the ability of 
xWnt8 to activate the b-catenin dependent pathway and cause dorsalization phenotypes 
in embryos. To test this, we used site-directed mutagenesis to disrupt amino acids on 
the thumb and index finger of xWnt8 that make key interactions with the CRD at Site 1 
and Site 2 (Figure 2.1). We demonstrate that mutations to the Site 2 interface inhibit the 
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signaling of xWnt8 in vivo (Figure 2.3), arguing that this binding surface plays an 
important role in the biology of the ligand. In contrast, our data reveal that xWnt8 
activates the b-catenin dependent pathway and binds to the CRD of xFz8 even when 
Site 1 residues, in particular the site of acylation, are mutated (Figures 2.3 – 2.5). Our 
findings challenge the hypothesis that acylation is required for biological activity of Wnts 
and argue that acylation-independent CRD binding can occur in vivo.   
 
2.2 Selection of xWnt8 point mutations 
We began our study with the prediction that, if the Site 1 and Site 2 interfaces are 
required for xWnt8 binding to Fz CRDs, then mutating key amino acids on the thumb or 
index finger will abolish signaling in vivo. Mutations were chosen to disrupt interactions 
seen in the xWnt8/mFz8-CRD crystal structure (Figure 2.1, Janda et al., 2012). Three 
xWnt8 variants were designed to progressively disrupt Site 2 binding (W319A, 
W319A/F317A, and W319A/F317A/V323A) – the triple mutant altering all Site 2 contact 
residues in xWnt8 except C321 (where changes would likely cause misfolding). K182S, 
K182S/W196A, and K182S/W196A/I186A variants were also generated to interrogate 
side chain-mediated interactions at Site 1. Separately, we replaced the acylation site 
serine (S187: Figure 2.1) with alanine to prevent acylation and thus investigate the 
importance of acylation in Fz binding. 
 
2.3 Development of a grading system for Wnt phenotypes 
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To assess the biological activity of the Site 1 and Site 2 mutants, we analyzed their 
ability to dorsalize Xenopus laevis embryos through the ectopic activation of the b-
catenin dependent pathway (McMahon and Moon, 1989; Sokol et al., 1991). In our 
assays, xWnt8 wild-type (xWnt8WT) was used as a positive control. Injection of mRNA 
encoding xWnt8WT into the equatorial region of a ventrally-fated cell (ventral marginal 
zone, VMZ) at the four-cell stage activates a gene signature, including the transcription 
Siamois and Xnr3, which causes the formation of an ectopic dorsal organizing center 
within the embryo (Lemaire et al., 1995; Brannon and Kimelman, 1996) (Kessler, 1997) 
(Smith et al., 1995) (McKendry et al., 1997; Fan and Sokol, 1997; De Robertis et al., 
2000). At low doses, Wnt injection causes bifurcation of the dorsal axis, resulting in 
partial (incomplete) or full (complete) duplication of dorsoanterior structures (Figure 2.2). 
At high doses, ectopic Wnt injection causes radial dorsalization of the embryo, similar to 
activation of the b-catenin dependent pathway by lithium treatment (Klein and Melton, 
1996), and characterized by severe shortening of the anterior-posterior axis. In extreme 
cases, embryos become completely cylindrical (Figure 2.2A, far right).  
To compare the severity of phenotypes caused by the Site 1 and Site 2 mutants, 
we created a novel grading system that represents each phenotype with a numerical 
score. As indicated in Figure 2.2, tailbud-stage embryos with a normal phenotype where 
given a score of zero, partial axis duplications a score of one, full axis duplications a 
score of two and radial dorsalization a score of three. Full axis duplications can be 
distinguished from partial axis duplications by the formation of a cement gland at the 
most anterior surface of the ectopic head (Figure 2.2B). For each mutant and dose, we 
summed the phenotype scores observed across each biological replicate and divided by 
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the total number of individuals analyzed. The resulting value falls on a 0 – 3 scale and is 
termed the mean dorsal score. 
 
2.4 Comparison of Site 1 and Site 2 mutations 
We next tested the ability of the xWnt8 Site 2 mutants to dorsalize Xenopus embryos 
upon ectopic expression of either 50 or 500pg of mRNA. For each mutant and dose, we 
calculated a mean dorsal score at the tailbud stages (Figure 2.3A, B).  To confirm that 
the observed phenotypes arose specifically from activation of the Wnt pathway, we 
collected injected embryos at the early gastrula stage (Nieuwkoop and Faber, NF, stage 
10) and measured the transcription of Wnt-specific gene targets Siamois and Xnr3 
(Figure 2.3C). xWnt8WT is highly active under these assay conditions, causing nearly 
complete radial dorsalization of embryos at both 50 and 500 pg doses of mRNA. The 
robust activation of the canonical pathway within these embryos is highlighted by the 
approximately ten-fold increase in the transcription of both Siamois and Xnr3.  
Even under conditions when xWnt8WT causes near-maximal dorsalization of 
embryos, we observed very little biological activity in our Site 2 mutants (Figure 2.3A-C). 
xWnt8W319A caused weak phenotypes at both 50 and 500 pg doses, but its activity is less 
than 500-fold that of WT (compare Figure 2.3A and 2.5A). we detected no phenotypes in 
embryos injected with either xWnt8W319A/F317A or xWnt8W319A/F317A/V323A. Furthermore, none 
of the Site 2 mutants induced Wnt-specific transcription of Siamois and Xnr3 (Figure 
2.3C). We reasoned that a decrease in total protein expression could account for the 
observed loss of activity of xWnt8. However, Western blotting analysis performed on 
whole embryo lysates demonstrated that all three Site 2 mutants are highly expressed in 
34	
	
the embryo (Figure 2.3D, bottom). These data argue that mutating even a single residue 
on the index finger of xWnt8 causes a near-total loss in biological activity. 
In contrast, the Site 1 mutations had minimal effects on the signaling of Wnt8 in 
vivo. The serine substitution at K182 – predicted to form a salt bridge with the E64 side-
chain in mFz8 (Janda et al., 2012) – had no effect on xWnt8 activity (Figure 2.3A). 
xWnt8K182S/W196A and xWnt8K182S/W196A/I186A variants failed to express (Figure 2.3D, top), 
making their lack of activity uninterpretable. Given the suggested importance of the 
S187-linked acyl chain for Wnt/Fz interactions, we were very surprised to find that 
replacing this residue with alanine had only a mild effect. Indeed, at 500 pg, xWnt8S187A 
radially dorsalizes embryos as effectively as WT (Figure 2.3A, B). xWnt8S187A also 
activates the transcription of Wnt-responsive genes Siamois and Xnr3 (Figure 2.3C). 
However, a dose-response analysis of xWnt8 phenotypes revealed a shift in the activity 
xWnt8S187A compared to xWnt8WT at lower mRNA concentrations. These signaling 
differences may arise due to changes in protein expression, localization, receptor affinity 
or antagonist interaction. We therefore measured the total expression of xWnt8 S187A in 
embryo lysates and found that it was not impaired, and in fact consistently measured 
higher than WT (Figure 2.3D, top and bottom).  
We next hypothesized that the S187A mutation may shift the cellular localization 
of xWnt8. A previous study demonstrated that mutating the site of acylation on Wnt3a 
(S209A) results in an accumulation of the ligand within the endoplasmic reticulum in both 
Xenopus embryos and cultured cells (Takada et al., 2006). To determine the localization 
of xWnt8 S187A in Xenopus tissues, we performed immunofluorescence staining on the 
animal hemisphere cells of blastula stage (NF stage 9) embryos expressing either 
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xWnt8WT or S187A. Surprisingly, our data do not support the hypothesis that preventing 
acylation causes ER retention. As shown in Figure 2.4, there is a similar distribution of 
xWnt8WT and xWnt8S187A between the nucleus and the cell periphery within Xenopus 
cells, which argues against a significant defect in intracellular trafficking of Wnt8S187A.  
The shift in activity we see between xWnt8WT and S187A may be a 
consequence of the role that acylation plays in shaping Wnt gradients. In many 
physiological contexts, Wnts remain tightly associated with the membranes of producing 
cells, which could promote local Wnt-responsiveness by restricting ligand diffusion 
(Papkoff and Schryver, 1990; Willert et al., 2003; Pfeiffer et al., 2002; Franch-Marro et 
al., 2008; Galli et al., 2007; Gao et al., 2011; Farin et al., 2016; Alexandre et al., 2014). 
The hydrophobicity of Wnts is dependent upon acylation, suggesting that the acyl tail 
may act to “anchor” Wnts within the cell membrane (Chen et al., 2009). In support of this 
argument, our immunofluorescence data show co-localization of xWnt8 and mem-GFP 
staining in cells expressing xWnt8WT but not S187A (Figure 2.4). These observations 
bear a striking resemblance to the role of acylation in the activity of the Drosophila 
EGFR ligand, Spitz. Like Wnts, inhibiting the acylation of Spitz significantly impairs its 
ability to pattern the eye imaginal disc of the Drosophila embryo (Miura et al., 2006). This 
defect arises not from changes in protein secretion or receptor binding, but a failure to 
tether ligands at the cell membrane and prevent their diffusion. The similarities between 
these two protein families highlights the importance of tethering in the function of 
acylated ligands and raises possibility that xWnt8 may be able to productively bind 
Fz/LRP complexes when acyl binding at Site 1 is prevented.   
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2.5 Acylation-independent signaling of xWnt8 
To further characterize the signaling of xWnt8S187A in vivo, we injected four-cell stage 
embryos at the VMZ with xWnt8WT or xWnt8S187A mRNA in doses ranging from 1 pg to 
500 pg/embryo. We analyzed dorsalization phenotypes at tailbud stages (Figure 2.5A, B) 
and expression of Siamois and Xnr3 at gastrula stage (Figure 2.5C). xWnt8S187A again 
displayed highly similar activity to xWnt8WT. Both proteins cause a dose-dependent 
increase in mean dorsal score and Wnt target gene expression (Figure 2.5A-C). Both 
proteins reach equivalent mean dorsal score and gene expression maxima at 500 pg 
injected mRNA. These data suggest that, at high doses, the biological activity of 
xWnt8WT and xWnt8S187A are highly similar.  Confirming our observations in Figure 2.3A, 
xWnt8 S187A displayed approximately ten-fold weaker activity compared to WT. Yet, 
Western blotting of whole embryos showed that the proteins are expressed at a similar 
magnitude (Figure 2.5D). We predict that the apparent shift in activity is likely due to a 
change in the behavior of the ligand within the extracellular space. These behaviors may 
include changes in affinity for extracellular binding partners (including receptors) or 
changes in local concentration caused by a Spitz-like diffusion mechanism. Yet, as 
demonstrated, xWnt8WT and S187A cause a nearly-identical frequency of the three 
dorsalization phenotypes (partial axis duplications, full axis duplications and radial 
dorsalization) when this shift is taken into account (compare 5 pg of xWnt8WT and 50 pg 
of xWnt8S187A in Figure 2.5A). These data show that non-acylated xWnt8 can induce very 
similar signaling consequences to acylated xWnt8 within the Xenopus embryo. 
 
2.6 Acylation-independent CRD binding of xWnt8 
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Since xWnt8 can signal in the absence of acylation, we next asked whether it could also 
bind to the CRDs of Fzs. As both biochemical (Hsieh et al., 1999; Janda et al., 2012) 
and in vivo (Deardorff et al., 1998) data support the hypothesis that Fz8 acts as a 
receptor for xWnt8, we chose to test the interaction of this receptor and ligand pair. A 
protein construct encoding only the CRD of Fz8 (Fz8 CRD) inhibits the dorsalizing 
activity of xWnt8WT in Xenopus embryos (Deardorff et al., 1998). If xWnt8S187A also binds 
Fzs, then we predicted that the co-expression of a soluble CRD construct should inhibit 
the signaling of both ligands. I tested this hypothesis by injecting 5 pg of xWnt8WT or 50 
pg of xWnt8S187A mRNA, either alone or in the presence of Xenopus (x)Fz8 CRD mRNA, 
into the VMZ of four-cell stage Xenopus embryos. I collected embryos at the gastrula 
stage (NF stage 10) and analyzed expression of Siamois and Xnr3. As shown in Figure 
2.6A, co-expression of the xFz8 CRD inhibits activation of the canonical Wnt pathway by 
either ligand. These data argue that acylation-independent signaling is equally sensitive 
to inhibition by the xFz8 CRD as wild-type. 
We next asked whether the xFz8 CRD binds xWnt8S187A in vivo. We co-
expressed xWnt8WT and xWnt8S187A with a myc-tagged version of the xFz8 CRD in 
Xenopus embryos and assessed their interaction by co-immunoprecipitation. As 
demonstrated in Figure 2.6B, both xWnt8WT and xWnt8S187A associate, in a dose-
dependent manner, with the xFz8 CRD. Interestingly, xWnt8WT associated more 
efficiently with the xFz8 CRD than xWnt8S187A. This shift could be a consequence of 
differences in receptor affinity or protein localization, and will require further study. 
Nevertheless, these data show that Wnts can bind Fzs in an acylation-independent 
manner and provide strong support to the argument that acylation at serine 187 is not 
required for xWnt8-dependent activation of the b-catenin dependent pathway.  
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2.7 Conclusion 
An outstanding question in the Wnt signaling field is how ligands recognize and activate 
cell surface receptors. The crystal structure of xWnt8 bound to the CRD of mFz8 
provided an important structural hypothesis for what receptor engagement might look 
like in vivo. Surprisingly, the structure predicted that the acyl tail on Wnts plays a direct, 
and essential, role in binding CRDs. While it has become accepted by many in the field 
that Wnt acylation is required for the biological activity of these ligands, the binding 
interfaces depicted in the crystal structure had not been validated in vivo. To address 
this gap in our knowledge, we investigated the contribution of the proposed 
crystallographic interfaces to the signaling of xWnt8 in Xenopus embryos. Our studies 
reveal that introducing point mutations at the Site 2 protein-protein interface potently 
interferes with the signaling of xWnt8. In contrast, mutating the site of acylation at Site 1 
only results in a mild attenuation in the signaling of the ligand. Importantly, non-acylated 
xWnt8 still engages the xFz8 CRD in vivo, as measured by immunoprecipitation. These 
data demonstrate that Wnts are capable of acylation-independent CRD binding and 
activation of the b-catenin dependent pathway.  
 Our data support the hypothesis that the residues of the Site 2 protein-protein 
interface are essential to the activity of xWnt8. We demonstrate that introducing even a 
single point mutation at the predicted binding surface (W319A) reduces the signaling of 
xWnt8 by more than 500-fold. Western blotting analysis illustrates that these point 
mutations do not cause defects in protein expression. To our knowledge, our data 
represent the first in vivo validation of the importance of Site 2 in the activity of a Wnt. 
Although we cannot rule out that the Site 2 mutations may cause defects in Wnt folding 
39	
	
and/or trafficking, they clearly provide an illustration of how a single point mutation at a 
key residue on the surface of xWnt8 potently reduces the signaling activity of the ligand.  
 In contrast, our data reveal that acylation is not required for productive binding 
between Wnts and Fzs. We show that mutating the site of acylation (S187A) on xWnt8 
does not cause the protein to become inactive, as predicted by the crystal structure. 
Instead, we observe an approximately ten-fold shift in activity of the non-acylated Wnt as 
compared to WT. However, if the ten-fold shift in activity is accounted for (comparing 
5pg of xWnt8WT to 50pg of xWnt8S187A in Figure 2.5A-C), the patterns of dorsalization 
and transcription are strikingly similar between the two proteins. These observations led 
us to hypothesize that a non-acylated Wnt may retain the ability to bind CRDs and 
activate Fz/LRP complexes at the cell surface. We used a soluble form of the xFz8 CRD 
to demonstrate that xWnt8 S187A can associate with Fz CRDs in vivo. In sum, our data 
demonstrate that the Site 1 acyl-protein interface is not absolutely required for the 
biological activity of xWnt8.  
Our data raise the important question of what CRD engagement by Wnts might 
look like in the absence of acylation. The question is difficult to answer as our 
understanding of Wnt structure is derived from a single, static, crystal structure and we 
therefore lack any information on the conformational flexibility of Wnts (Janda et al., 
2012). With these restrictions in mind, we propose two simple possibilities for the 
mechanisms of acylation-independent Wnt/CRD binding. First, that acylation-
independent binding to CRDs uses many of the same protein-protein interfaces seen in 
the crystal structure. Accumulating evidence in the field supports the hypothesis that the 
Site 2 interface on Fz CRDs may provide a common binding surface for both acylated 
and non-acylated ligands. The atypical ligand Norrin engages the CRD of Fz4 at Site 2 
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(Chang et al., 2015; Shen et al., 2015). Furthermore, binding studies performed using a 
“mini-Wnt,” containing only the index finger domain of xWnt8, demonstrate that the Site 
2 interaction can form independently of the acyl-protein interface at Site 1(Janda et al., 
2012). In contrast, it is also quite possible that acylation-independent binding to CRDs 
requires protein-protein interfaces unrelated to those described in the crystal structure. 
Combining structural and in vivo studies will provide the most direct means for identifying 
the nature of these interactions.    
 A growing body of literature supports the essential role of Wnt acylation in protein 
secretion, extracellular distribution and receptor binding (Nusse and Clevers, 2017). We 
observe that the in vivo activity of xWnt8S187A is approximately ten-fold weaker than its 
WT counterpart. Thus, our studies confirm that acylation plays an important role in the 
signaling of xWnt8 even though it is not essential for CRD binding. To investigate this 
shift in signaling further, we began with the hypothesis that xWnt8 may require acylation 
to exit the ER, as proposed in a previous study (Takada et al., 2006). However, our 
immunofluorescence data did not reveal a significant defect in intracellular trafficking of 
xWnt8S187A (Figure 2.4). Although these data provide evidence that preventing acylation 
does not cause ER retention of Wnt ligands in Xenopus embryos, they do not directly 
address potential differences in the efficiency of Wnt secretion into the extracellular 
space. Indeed, performing direct measurements of the rates of secretion will be an 
important future direction for this project.  
We next proposed that acylation may play a role in tethering Wnts, as 
demonstrated for the Drosophila EGFR ligand, Spitz (Miura et al., 2006). Wild-type Wnts 
are known to associate strongly with the cell membranes of producing cells (Papkoff and 
Schryver, 1990; Willert et al., 2003; Pfeiffer et al., 2002; Franch-Marro et al., 2008; Galli 
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et al., 2007; Gao et al., 2011). Similarly, we observed an accumulation of xWnt8 at the 
cell periphery of producing cells in Xenopus tissues and this association was dependent 
upon the presence of the acyl tail. However, could a defect in tethering be sufficient to 
cause a ten-fold shift in the apparent biological activity of a ligand? Studies of Spitz 
confirm that preventing acylation can cause significant attenuation of ligand signaling 
without affecting receptor affinity (Miura et al., 2006). However, in the case of Wnts, we 
cannot rule a that acylation may be also contributing to high-affinity interactions between 
Wnts and CRDs. In summary, we demonstrate that Wnts may engage CRDs and 
activate the b-catenin dependent pathway through acylation-independent mechanisms. 
Yet, the signaling differences we see between acylation and non-acylated Wnts argues 
that this modification is required for the full biological activity of these ligands. A 
biochemical approach will be necessary to understand the relative contributions of 
acylation to receptor engagement and membrane tethering. 
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Figure 2.1. Selection of Site 1 and Site 2 point mutations. 
 
  
A
B
palmitoleate 
(acylation)
Site 1
Site 2
S187
I186
K182
W196“
th
um
b”
“index finger”
W319
F317
V323
xWnt8 WT         CKCHGISGSCSIQTCW
xWnt8   S187A      CKCHGIAGSCSIQTCW  
mWnt1   WT         CKCHGMSGSCTVRTCW  
mWnt1   S224A      CKCHGMAGSCTVRTCW  
hWnt3a  WT         CKCHGLSGSCEVKTCW  
hWnt3a  S209A      CKCHGLAGSCEVKTCW  
mWnt5a  WT         CKCHGVSGSCSLKTCW  
mWnt5a  S244A      CKCHGVAGSCSLKTCW  *****: *** ::*** 
43	
	
Figure 2.1. Selection of Site 1 and Site 2 point mutations. (A) Point mutations were 
introduced into xWnt8 to perturb the Site 1 and Site 2. Amino acids on xWnt8 were 
selected based on their contributions to binding. Mutations K182S, K182S + W196A and 
K182S + W196A + I186A were made to abolish protein-protein interactions at Site 1. 
Serine 187 is the site of acylation on xWnt8, and a S187A mutation was introduced to 
disrupt protein-lipid interactions. The following constructs: W319A, W319A + F317A, 
W319A + F317A +V323A were created to abolish protein-protein interfaces at Site 2. (B) 
Sequence surrounding the highly-conserved serine acylation site in Wnt family members 
studied here. Site-directed mutagenesis was used to replace the acylated serine in 
xWnt8, mWnt1, hWnt3a, and mWnt5a with alanine. Other amino acids in the alignment 
correspond to residues on the “thumb” of xWnt8 immediately surrounding the acylated 
serine. DNA constructs were sequenced at the DNA Sequencing Facility at the 
University of Pennsylvania, translated using the Sequence Manipulation Suite 
(http://www.bioinformatics.org) and aligned using the Clustal Omega multiple sequence 
alignment tool (http://www.ebi.ac.uk/Tools/msa/clustalo).  
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Figure 2.2. A grading scale for Wnt phenotypes.
  
normal = 0
partial = 1
full = 2
radial = 3
Partial axis duplication Full axis duplication
primary dorsal axis
duplication of dorsoanterior structures
cement gland
A
B
45	
	
Figure 2.2. A grading scale for Wnt phenotypes. (A) The three categories of Wnt-
dependent dorsalization phenotypes observed upon ectopic expression of Wnts from the 
VMZ of four-cell stage embryos. Pictures show representative tailbud-stage Xenopus 
embryos with their corresponding phenotype scores. Low levels of ectopic Wnt signaling 
cause the formation of a Siamese twin (extra tissue in foreground, indicated by arrows). 
Twins contain, at minimum, duplication of neural and dorsal mesodermal tissues 
(“partial”, score = 1, yellow arrow). They may also contain a complete head, including the 
darkly-pigmented anterior cement gland (“full”, score = 2, black arrow). High levels of 
ectopic Wnt signaling result in severe shortening of the anterior-posterior axis (“radial”, 
score = 3, red arrow). (B) Calculating the mean dorsal score. Mean dorsal scores were 
calculated by summing the individual phenotype scores across all biological replicates 
and dividing by the total number of observations. 
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Figure 2.3. Comparing Site 1 and Site 2 mutations. 
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Figure 2.3. Comparing Site 1 and Site 2 mutations. (A) Site 2 mutants abolish 
signaling of xWnt8, but Site 1 mutations only cause a mild attenuation in activity. xWnt8 
mRNA was injected into the VMZ of four-cell stage embryos. Mean dorsal scores were 
calculated at tailbud stages by summing individual phenotype scores (0-3 scale) within a 
treatment group and dividing by the population size. Numbers above bars indicate the 
total embryos scored across the biological replicates. N=3 for WT, S187A, W319A, 
W319A + F317A and W319A + F317A + V323A. N=1 for K182S, K182S + W196A and 
K182S + W196A + I186A. Mean dorsal scores for xWnt8WT and xWnt8S187A are from the 
data set shown in Figure 2.5A and are represented here for comparison. (B) Pictures 
show representative phenotypes caused by 0 pg or 500 pg injected mRNA. Red arrows 
= radial dorsalization. (C) Site 2 mutants do not activate the transcription of Wnt-
responsive genes Siamois and Xnr3. xWnt8 mRNA was injected into the VMZ of four-
cell stage embryos. At the early gastrula stage (stage 10), embryos were collected and 
the transcription of Wnt target genes assessed by RT-PCR. Each replicate was 
normalized to the 500 pg xWnt8WT treatment condition and are represented as mean ± 
SEM (n=3). Statistical significance was assessed using a fixed effects regression model 
with controls (0 pg) as a reference group. ns = p ³ 0.05, *p £ 0.05, **p £ 0.01 and ***p £ 
0.001. (D) Mutations at S187 and Site 2 do not decrease expression of xWnt8 protein. 
xWnt8 mRNA was injected into the VMZ of four-cell stage embryos. Embryos were 
collected at the gastrula stage (stage 10.5). Five embryos per treatment group were 
homogenized and one embryo equivalent of whole-embryo lysate was probed by 
Western blot for xWnt8 expression (n=1 for top Western, n=3 for bottom Western).  
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2.4. Immunofluorescence staining of xWnt8WT and xWnt8S187A. 
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2.4. Immunofluorescence staining of xWnt8WT and S187A. xWnt8WT and xWnt8S187A 
have different distributions in Xenopus tissues. Two-cell stage embryos were first 
injected at both cells with 500 pg memGFP mRNA. Embryos were then allowed to 
develop until the 32-cell stage, when one animal pole cell was injected with 1 ng of 
xWnt8WT or xWnt8S187A mRNA. At the late blastula stage (stage 9), tissues of the animal 
pole were surgically removed, fixed, stained using standard protocols, and imaged by 
confocal microscopy (n=2). Far right images show magnification of boxed region in 
central panels. Scale bar, 20 µm (left and center panels) and 5 µm (right panels). 
Brightness and contrast were adjusted for clarity of viewing. 
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Figure 2.5. xWnt8 is biologically active in the absence of acylation. 
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Figure 2.5. xWnt8 is biologically active in the absence of acylation. (A) xWnt8S187A 
dorsalizes Xenopus embryos. xWnt8WT or xWnt8S187A mRNA was injected into the VMZ 
of four-cell stage embryos and embryos were scored at the tailbud stage. Numbers 
above bars (left) indicate the total embryos scored across (n=4) biological replicates. 
Data are represented as both mean dorsal score (left) and phenotype frequency (right) 
(B) Pictures show representative phenotypes from one biological replicate. Yellow 
arrows = partial duplication, black arrows = full duplication, red arrows = radial 
dorsalization. (C) xWnt8S187A activates the transcription of Wnt-responsive genes. 
xWnt8WT or xWnt8S187A mRNA was injected into the VMZ of four-cell stage embryos. At 
early gastrula stage (stage 10), embryos were collected and Siamois and Xnr3 transcript 
levels measured by RT-PCR. Each replicate was normalized to the 500 pg xWnt8WT 
treatment condition and are represented as mean ± SEM (n=3). Statistical significance 
was assessed using a fixed effects regression model with controls (0pg) used as a 
reference group followed by a Wald chi-square test for pair-wise comparisons. ns = p ³ 
0.05, *p £ 0.05, **p £ 0.01 and ***p £ 0.001. (D) xWnt8WT and xWnt8S187A are expressed 
at a similar magnitude. xWnt8WT and xWnt8S187A mRNA were injected into the VMZ of 
four-cell stage embryos. Five embryos per treatment were collected at gastrula stage 
(stage 10.5), homogenized, and one embryo equivalent of whole cell lysate was probed 
by Western (n=3).  
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Figure 2.6. xWnt8WT and xWnt8S187A bind to the xFz8 CRD 
 
  
A
B
* * *
* * *
xWnt8WT (5 pg)
xWnt8S187A (50 pg)
xFz8 CRD (1000 pg)
+
-
+
-
+
+
-
+
-
+
-
-
-
-
-
Siamois
0
50
100
150
%
 P
os
iti
ve
 c
on
tr
ol
* * *
* * *
+
-
+
-
+
+
-
+
-
+
-
-
-
-
-
Xnr3
0
50
100
150
%
 P
os
iti
ve
 c
on
tr
ol
xWnt8WT (5 pg)
xWnt8S187A (50 pg)
xFz8 CRD (1000 pg)
α-xWnt8
α-xWnt8
α-myc
blot
α-myc
 xWnt8WT (pg) - - 1000- - - 50 250 1000
 xWnt8S187A (pg) - 1000 -50 250 1000 - - -
 xFz8 CRD-myc (1000 pg) - -+ + + + + + +
m
yc
 IP
In
pu
t
53	
	
Figure 2.6. xWnt8WT and xWnt8S187A bind to the xFz8 CRD. (A) xWnt8WT and 
xWnt8S187A are sensitive to inhibition by the xFz8 CRD. xWnt8 and xFz8 CRD mRNA 
were co-injected into the VMZ of four-cell stage embryos. At the early gastrula stage 
(stage 10), embryos were collected and Siamois and Xnr3 levels measured by RT-PCR. 
Each replicate was normalized to the 5 pg xWnt8WT treatment condition and are 
represented as mean ± SEM (n=4). Statistical significance was assessed using a fixed 
effects regression model with xWnt8WT 5 pg as the reference group. (B) xWnt8WT and 
xWnt8S187A physically interact with the xFz8 CRD in vivo. xWnt8 and xFz8 CRD-myc 
mRNA were co-injected into both cells of a two-cell stage embryo. Embryos were 
collected at the gastrula stage (stage 10.5). Precipitation of xFz8 CRD-myc was 
performed with an a-myc (9E10) antibody and Wnt interaction was detected by Western 
blotting. The band present in lanes 2 and 6 of the a-myc IP blot is likely a signal from the 
heavy chain of 9E10, as it runs at an identical molecular weight to the xFz8 CRD-myc 
protein (n=3). 
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Chapter 3: Acylation dependencies within the Wnt family 
3.1 Introduction 
Wnts are a family of morphogens that play diverse roles in embryonic patterning, the 
maintenance of adult stem cell populations, and the promotion of cancer. Interestingly, 
genetic studies of the ancient phylum Cnidaria reveal conservation of 11 of 12 
mammalian Wnt subfamilies, suggesting that an almost full complement of Wnts arose 
early in the history of metazoans (Guder et al., 2006). Such high levels of conservation 
imply a strong evolutionary pressure to preserve diversity within this ligand family. 
Although our understanding of Wnt signaling has greatly advanced in the past decades, 
whether functional diversity exists within the many members of the Wnt family remains 
unclear.  
 Diversity within the Wnt family likely provides opportunities for both pre- and 
post-translational control of signaling outcomes. Transcriptional regulation of Wnt 
expression provides a mechanism for restricting when and where the different signaling 
pathways are activated (Logan and Nusse, 2004). At the post-transcriptional level, Wnts 
can be divided into two functional classes based on the phenotypes they elicit in 
Xenopus embryos. Wnts 1, 3a and 8 activate the b-catenin dependent pathway and 
cause ectopic dorsalization of embryos (McMahon and Moon, 1989; Sokol et al., 1991). 
In contrast, Wnts 5a and 11 selectively activate the PCP pathway and cause disruption 
of convergence and extension movements during gastrulation (Du et al., 1995). These 
simple assays argue that Wnts have significantly different affinities for receptors at the 
cell surface. However, the structural basis for these unique patterns of receptor 
interaction remain unclear.  
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Categorizing Wnts into two distinct functional classes is likely an 
oversimplification of structural differences between ligands, but biochemical studies have 
yet to yield information on what makes Wnts unique. Binding studies demonstrate that 
Wnts have overlapping affinities for Fzs (Hsieh et al., 1999; Deardorff et al., 2001; Ring 
et al., 2014; Dijksterhuis et al., 2015). Evidence from the xWnt8/mFz8 CRD crystal 
structure also reinforces the perceived redundancy in Wnt/Fz interactions. At Site 1, 
acylation is conserved throughout the vertebrate Wnt family, suggesting that all Wnts 
may rely on the acyl-protein interface for CRD binding (Janda et al., 2012). In addition, 
the amino acids on the thumb and forefinger of xWnt8 represent some of the most 
highly-conserved sequences in the entire protein. In sum, all evidence points to Wnts 
engaging Fzs through similar mechanisms.  
The data presented in Chapter 2 challenges the assumption that all Wnts require 
acylation for their biological activity. An important question arising from these studies is 
whether all members of the Wnt family share the same capacity for acylation-
independent signaling. To test this hypothesis, we introduced point mutations to the 
acylated serine residues on Wnts 1, 3a and 5a. For Wnts 1 and 3a, we analyzed their 
ability to activate the  b-catenin dependent pathway and cause dorsalization of Xenopus 
embryos. For Wnt5a, we asked whether a non-acylated ligand could cause convergent 
extension phenotypes in Xenopus embryos.  
Our results demonstrate that Wnts have unique dependencies on acylation for 
their biological activities. Wnt3a, like xWnt8, is capable of acylation-independent 
activation of the b-catenin dependent pathway and CRD binding. In contrast, both Wnts 
1 and 5a demonstrate no detectable biological activity in Xenopus embryos when 
acylation was prevented. Our findings argue that Wnts have unique structural 
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requirements for signaling in vivo and we suggest that this structural diversity may 
translate into previously-unappreciated functional differences between individual ligands.  
 
3.2 Acylation-dependent signaling of mWnt1 
The observation that xWnt8 is capable of acylation-independent signaling prompted us 
to examine whether other canonical Wnts have the same capacity. In Drosophila, the 
signaling of Wg is strongly attenuated when acylation is prevented (Franch-Marro et al., 
2008). Therefore, we asked whether murine (m)Wnt1 dorsalizes Xenopus embryos 
when its site of acylation is mutated (S224A, Figure 2.1B). We injected between 1 pg 
and 500 pg of mRNA encoding mWnt1WT or mWnt1S224A into the VMZ of four-cell stage 
Xenopus embryos and measured dorsalization phenotypes. mWnt1WT caused the 
dorsalization of embryos at doses as low as 1 pg injected mRNA, similar to xWnt8WT 
(compare Figure 2.5A, B and Figure 3.1A, B). However, we observed no phenotypes in 
mWnt1S224A-expressing embryos up to 500 pg injected mRNA and very low frequency 
partial axis duplications at 1000 pg injected mRNA (data not shown). mWnt1S224A also 
failed to induce the transcription of Siamois or Xnr3 at any dose of mRNA tested (Figure 
3.1C). Yet, we show by Western blot that mWnt1S224A is expressed to a similar 
magnitude, even slightly higher, than its WT counterpart (Figure 3.1D). These data 
suggest that Wnt1, in contrast to Wnt8, is highly dependent upon acylation for its 
biological activity in Xenopus embryos.  
 The loss in signaling activity observed with the mWnt1S224A mutation prompted us 
to examine whether acylation is required by mWnt1 for CRD binding. We first sought 
establish whether mWnt1WT, like xWnt8, binds the xFz8 CRD. We co-expressed 
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mWnt1WT with the soluble xFz8 CRD from the VMZ of four-cell stage embryos and 
measured levels of Siamois and Xnr3 transcription. mWnt1 WT is also sensitive to 
inhibition by the xFz8 CRD, suggesting that the two proteins may bind in vivo (Figure 
3.2A). We next asked whether the site of acylation on mWnt1 is required for xFz8 CRD 
binding. We co-expressed mWnt1WT or mWnt1S209A and xFz8 CRD-myc mRNA from the 
animal blastomeres of two-cell stage embryos and measured their interaction by co-
immunoprecipitation. The xFz8 CRD binds to both mWnt1WT and mWnt1S224A in a dose-
dependent manner (Figure 3.2B). These data argue that, while acylation is not 
absolutely required for Wnt1 binding to CRDs, it is necessary for the activation of 
intracellular signaling. Our experiments reveal striking differences between Wnts 1 and 8 
and argue that canonical Wnts may be a structurally, and functionally, diverse group of 
ligands.  
 
3.3 Acylation-independent signaling of hWnt3a 
The distinct acyl dependencies of Wnts 1 and 8 prompted us to examine whether the 
activity of either ligand is unique amongst the Wnt family. We next performed 
experiments to determine whether Wnt3a, also an activator of the canonical signaling 
pathway, behaves in a more Wnt8-like or Wnt1-like manner when acylation is prevented. 
We expressed hWnt3aWT and hWnt3aS209A (Figure 2.1B) from the VMZ of four-cell stage 
embryos and measured the activation of the canonical Wnt pathway, as assessed by the 
transcription of Wnt-responsive genes and the dorsalization of tailbud stage embryos. 
Like xWnt8S187A, hWnt3aS209A caused dose-dependent dorsalization of Xenopus embryos 
and elevated the transcription of both Siamois and Xnr3 (Figure 3.3A-C). However, 
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hWnt3a S209A induced fewer full axis duplications than hWnt3a WT (Figure 3.3A, right). 
Western blotting analysis performed on whole embryo lysates confirmed that mutating 
the site of acylation does not significantly change hWnt3a expression (Figure 3.3D). Yet, 
similar to xWnt8, hWnt3aS209A displays approximately ten-fold weaker activity than 
hWnt3aWT (compare 10 pg WT to 100 pg S209A in Figure 3.3A, B). These data suggest 
that both Wnts 8 and 3a can activate signaling through acylation-independent 
mechanisms but require acylation for full biological activity. We next examined whether 
hWnt3aS209A could also interact with Fz CRDs, as seen for Wnts 8 and 1. We show that 
signaling by hWnt3aWT and hWnt3aS209A is inhibited by the soluble xFz8 CRD (Figure 
3.4A). Furthermore, co-immunoprecipitation assays demonstrate that both hWnt3aWT 
and hWnt3aS209A physically bind the xFz8 CRD in vivo (Figure 3.4B). 
 
3.4 Acylation-dependent signaling of mWnt5a  
We next sought to address the role of acylation in Wnts regulating the non-canonical, or 
planar cell polarity, pathway. We chose to test the acylation-independent signaling of 
Wnt5a, which participates in the morphogenesis of many vertebrate tissues (Oishi et al., 
2003), notably the convergent extension movements of the gastrulating Xenopus 
embryo (Figure 3.5A, Wallingford et al., 2001; Schambony and Wedlich, 2007). We 
therefore asked whether acylation is required for the ability of murine (m)Wnt5a to 
disrupt convergence extension movements in Xenopus embryos. We expressed 
mWnt5aWT and acyl mutant (S244A, Figure 2.1B) from the upper dorsal marginal zone 
(DMZ) of four-cell stage embryos. By monitoring phenotypes at the neurula stage, we 
determined that ectopic expression of Wnt5aWT resulted in a dose-dependent increase in 
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convergence extension phenotypes between 10 and 100 pg injected mRNA (Figure 
3.5B,C). In contrast, mWnt5aS244A did not induce significant convergence extension 
defects in this assay. Severe blastopore closure defects occurred upon injection of 500 
pg or 1000 pg of mWnt5aWT or mWnt5aS244A mRNA, making it difficult to assess defects 
in convergence and extension at these mRNA concentrations. We note phenotypes 
were significantly distinct from those caused by mWnt5aWT at lower concentrations and 
we conclude that they likely reflect toxicity (data not shown). Western blotting performed 
on whole embryo lysates indicated that both mWnt5aWT and mWnt5aS244A are expressed 
at equal magnitudes (Figure 3.5D). Although it remains unclear which receptors directly 
engage Wnt5a and which are involved in concurrent signaling events, these data 
suggest that Wnt5a, like Wnt1, is dependent upon acylation for signaling. 
 Although it appears that most functions of Wnt5a in vivo occur through the 
activation of the noncanonical Wnt pathway, Wnt5a also stimulates the canonical 
pathway when co-expressed with the certain Fzs (He et al., 1997; Mikels et al., 2006). 
This observation provided us with the opportunity to compare the role acylation in the 
activation of the canonical and noncanonical pathways, which have distinct receptor 
requirements. To measure the activation of the canonical pathway, we co-expressed 5 – 
500pg of Wnt5aWT or Wnt5aS244A mRNA with 50pg of Fz5 mRNA from the VMZ of a 
single cell in a four-cell stage embryo. At the tadpole stage, we analyzed the phenotypes 
arising from co-injections. We noted that, at low doses, the co-expression of Wnt5aWT 
and Fz5 mRNA caused dorsalization phenotypes, as seen for Wnts 8, 1 and 3a (Figure 
3.5E, WTdorsal and S244Adorsal bars, and 3.5F Dorsal phenotypes). However, at higher 
doses (between 100 – 500pg of mRNA), we observed that the phenotypes became 
highly similar to the convergent extension phenotypes seen in Figure 3.5B (Figure 3.5E, 
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WTCE and S244ACE, and 3.5F CE phenotypes). Therefore, we chose to represent both 
phenotypes as a percentage of the total population. As we observed for our 
noncanonical assays, Wnt5aWT induced dose-dependent activation of the canonical 
pathway, whereas Wnt5aS244A caused no observable phenotypes. An important caveat of 
these data is that they represent only one biological replicate, and should be repeated 
before strong conclusions are drawn. Nevertheless, they argue that Wnt5a requires 
acylation to productively activate both the canonical and noncanonical pathways.  
 
3.5 Conclusion 
In Chapter 2, we demonstrated that xWnt8 was capable of acylation-independent 
activation of the b-catenin dependent pathway within the Xenopus embryo. Our data 
directly challenged the prediction from the xWnt8/mFz8 CRD crystal structure that 
acylation is required by Wnts for receptor recognition. There are 19 members of the Wnt 
family of ligands which are all predicted to bind to Fz CRDs in vivo (Niehrs, 2012). 
Furthermore, Fz-dependent signaling controls the activation of both the b-catenin 
dependent pathway and the PCP pathway. Therefore, an important question arising from 
the data presented in Chapter 2 was whether the acylation-independent signaling 
observed for xWnt8 represents a universal trait of all Wnts or specific characteristic of 
certain ligands.  
In Chapter 3, we investigated the role of acylation in the signaling of unique 
Wnts. Wnts 1 and 3a, like Wnt8, activate the b-catenin dependent pathway and cause 
dorsalization phenotypes in Xenopus embryos. Furthermore, receptor synergy studies 
demonstrate that all three Wnts have highly-overlapping patterns of Fz binding in vivo 
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(Deardorff et al., 2001). Therefore, we predicted that all three ligands would have a 
similar dependency on acylation for their biological activities. On the contrary, we found 
that acylation-independent signaling is a unique characteristic even among Wnts with 
redundant signaling outcomes. Wnts 8 and 3a define a subclass of ligands that are 
capable of signaling through acylation-independent mechanisms. xWnt8S187A, despite the 
ten-fold shift in its activity, is indistinguishable from xWnt8WT in the quality and quantity of 
phenotypes it produces. Interestingly, ectopic hWnt3aS209A expression yields quantities of 
phenotypes equal to hWnt3aWT, but the quality, as measured by the number of full axis 
duplications induced in embryos, is markedly different. These data suggest that, even 
amongst Wnts capable of acylation-independent signaling, this modification may play 
ligand-specific roles.  
In contrast, Wnt1 is dependent upon acylation for the activation of the canonical 
pathway. Although Wnt1S209A was still capable of physically associating with the xFz8 
CRD, it was unable to activate signaling in vivo. Wnt1 may be dependent upon acyl 
binding at the Site 1 interface to productively engage Fzs. Alternatively, Wnt1 may have 
lower affinity than Wnts 8 and 3a for the Fzs (7 and 4) expressed during the 
developmental window when ectopic dorsalization occurs (Medina et al., 2000; Shi and 
Boucaut, 2000). Thus, “untethering” of Wnt1 from the cell membrane would more 
efficiently reduce its concentration below the threshold required to activate signaling. 
Wnt5a, like Wnt1, also requires acylation for its ability to activate both the canonical and 
noncanonical pathways, thereby demonstrating that neither acylation-dependent nor 
acylation-independent signaling is unique amongst Wnts. Our data argue that Wnts have 
distinct structural characteristics that may play an important role in regulating receptor 
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recognition. Further discussion of the structural relationships between unique Wnts and 
Fzs and are presented in Chapter 4. 
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Figure 3.1. mWnt1 requires acylation for biological activity.
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Figure 3.1. mWnt1 requires acylation for biological activity. (A) mWnt1S224A does not 
dorsalize Xenopus embryos. mWnt1WT or mWnt1S224A mRNA was injected into the VMZ 
of four-cell stage embryos. Mean dorsal scores were calculated at the tailbud stage. 
Numbers above bars indicate the total embryos scored across (n=3) biological 
replicates. (B) Pictures show representative phenotypes from one biological replicate. 
Yellow arrows = partial duplication, black arrows = full duplication, red arrows = radial 
dorsalization. (C) mWnt1S224A does not activate the transcription of Wnt-responsive 
genes. mWnt1WT and mWnt1S224A mRNA were injected into the VMZ of four-cell stage 
embryos. Embryos were collected at the early gastrula stage (stage 10) and transcription 
of Siamois and Xnr3 were analyzed by RT-PCR. Each replicate was normalized to the 
500 pg mWnt1WT treatment condition and are represented as mean ± SEM (n=3). 
Statistical significance was assessed using a fixed effects regression model with controls 
(0pg) used as a reference group followed by a Wald chi-square test for pair-wise 
comparisons. ns = p ³ 0.05, *p £ 0.05, **p £ 0.01 and ***p £ 0.001. (D) mWnt1WT and 
mWnt1S224A are expressed at similar levels within the embryo. mWnt1WT or mWnt1S224A 
mRNA was injected into the VMZ of four-cell stage embryos. At the gastrula stage (stage 
10.5), five embryos per treatment group were collected, homogenized, and one embryo 
equivalent of whole embryo lysate was probed by Western blot (n=2). Wnt1 protein can 
be detected as four separate species which are indicated by black circles.  
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Figure 3.2. mWnt1WT and mWnt1S224A bind to the xFz8 CRD.
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Figure 3.2. mWnt1WT and mWnt1S224A bind to the xFz8 CRD. (A) mWnt1WT signaling is 
sensitive to inhibition by the xFz8 CRD. mWnt1WT and xFz8 CRD mRNA were co-
injected into the VMZ of four-cell stage embryos. Embryos were collected at the early 
gastrula stage (stage 10) and Siamois and Xnr3 levels measured by RT-PCR. Each data 
set was normalized to the 5 pg mWnt1WT treatment condition and are represented as 
mean ± SEM (n=3). Statistical significance was assessed using a fixed effects 
regression model with mWnt1WT 5 pg as the reference group. (B) mWnt1WT and 
mWnt1S224A physically associate with the xFz8 CRD in vivo. mWnt1 and xFz8 CRD-myc 
mRNA were co-injected into both cells of a two-cell stage embryo. Embryos were 
collected at gastrula stage (stage 10.5), precipitation of xFz8 CRD-myc was performed 
with an a-myc (9E10) antibody, and mWnt1 was detected by Western blotting. Wnt1 
protein can be detected as four separate species which are indicated by the black 
circles. The band present in lanes 2 and 6 of the a-myc IP blot is likely a signal from the 
heavy chain of 9E10, as it runs at an identical molecular weight to xFz8 CRD-myc. 
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Figure 3.3. hWnt3a is biologically active in the absence of acylation. 
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Figure 3.3. hWnt3a is biologically active in the absence of acylation. (A) 
hWnt3aS209A dorsalizes Xenopus embryos. hWnt3aWT and hWnt3aS209A mRNA were 
injected into the VMZ of four-cell stage embryos and phenotypes were calculated at the 
tailbud stage. Data is represented as mean dorsal score (left) and phenotype frequency 
(right). Numbers above bars (left) indicate the total individuals scored across (n=3) 
biological replicates. (B) Pictures show representative embryos from one biological 
replicate. Yellow arrows = partial duplication, black arrows = full duplication, red arrows = 
radial dorsalization. (C) hWnt3aWT and hWnt3aS209A both upregulate the transcription of 
Wnt-responsive genes. hWnt3aWT or hWnt3aS209A mRNA were injected into the VMZ of 
four-cell stage embryos. Embryos were collected at early gastrula stage (stage 10) and 
the expression of Siamois and Xnr3 analyzed by RT-PCR. Each replicate was 
normalized to the hWnt3aWT 100 pg treatment condition and are represented as mean ± 
SEM (n=3). Statistical significance was assessed using a fixed effects regression model 
with controls (0pg) used as a reference group followed by a Wald chi-square test for 
pair-wise comparisons. ns = p ³ 0.05, *p £ 0.05, **p £ 0.01 and ***p £ 0.001. (D) hWnt3a 
WT and S209A are expressed at similar magnitudes. hWnt3aWT or hWnt3aS209A mRNA 
was injected into the VMZ of four-cell stage embryos. Embryos were collected at 
gastrula stage (stage 10.5), homogenized, and two embryo equivalents of whole-embryo 
lysate were probed by Western blot for Wnt3a expression (n=3). hWnt3a runs at the 
same gel position as a ~40 kDa endogenous protein.  
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Figure 3.4. hWnt3a WT and S209A bind to the xFz8 CRD.
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Figure 3.4. hWnt3aWT and hWnt3aS209A bind to the xFz8 CRD. (A) Both hWnt3aWT and 
hWnt3aS209A are sensitive to inhibition by the xFz8 CRD. hWnt3a and xFz8 CRD mRNA 
were co-injected into the VMZ of four-cell stage embryos. Embryos were collected at the 
early gastrula stage (stage 10) and the transcription of Siamois and Xnr3 measured by 
RT-PCR. Each replicate was normalized to the 5 pg hWnt3aWT treatment condition and 
are represented as mean ± SEM (n=3). Statistical significance was assessed using a 
fixed effects regression model with hWnt3aWT 5 pg as the reference group. ns = p ³ 0.05, 
*p £ 0.05, **p £ 0.01 and ***p £ 0.001. (B) hWnt3aS209A binds the xFz8 CRD. hWnt3a and 
xFz8 CRD-myc mRNA were co-injected into both cells of a two-cell stage embryo. 
Embryos were collected at the gastrula stage (stage 10.5). Precipitation of the xFz8 
CRD-myc was performed with an a-myc (9E10) antibody and Wnt interaction was 
detected by Western blotting (n=3). hWnt3a runs at the same gel position as a ~40 kDa 
endogenous protein in the Input blot. The band present in lanes 2 and 6 of the a-myc IP 
blot is likely a signal from the heavy chain of 9E10, as it runs at an identical molecular 
weight to the xFz8 CRD-myc protein. 
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Figure 3.5. mWnt5a requires acylation for its biological activity.  
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Figure 3.5. mWnt5a requires acylation for its biological activity. (A) Wnt5a causes 
convergent extension phenotypes in embryos. Ectopic expression of noncanonical 
Wnt5a from the DMZ of four-cell stage embryos causes the disruption of convergence 
and extension movements of the neural and dorsal mesodermal tissues of the embryo, 
resulting in a shortening and curvature to the anterior-posterior axis. (B) mWnt5a 
requires acylation to cause convergent extension defects in Xenopus embryos. 
mWnt5aWT or mWnt5aS244A mRNA was injected into the DMZ of four-cell stage embryos 
and convergent extension phenotypes were scored at neurula stages. Data is 
represented as the percentage of individuals displaying convergence and extension 
defects. Numbers above bars represent the total individuals scored across (n=3) 
biological replicates. (C) Pictures show representative phenotypes from one biological 
replicate. (D) Mutating the site of acylation does not decrease mWnt5a protein 
expression. mWnt5aWT or mWnt5aS244A mRNA was injected into the DMZ of four-cell 
stage embryos. At the gastrula stage (stage 10.5), embryos were collected, 
homogenized, and two embryo equivalents of whole cell lysate were probed by Western 
blot for the expression of Wnt5a. (E) Wnt5a requires acylation to cause dorsalization 
defects in Xenopus embryos. mWnt5aWT or mWnt5aS244A mRNA was co-injected with 
50pg of Fz5 mRNA into the VMZ of four-cell stage embryos and phenotypes were 
analyzed at the tailbud stages (n=1). Phenotype frequency, instead of mean dorsal 
score, is represented in order to illustrate that both dorsalization and convergent 
extension defects occur with Wnt5aWT and Fz5 co-expression. (F) Representative 
embryos demonstrating the dorsalization phenotypes caused by low doses of Wnt5aWT + 
Fz5 (right) and convergent extension (CE) phenotypes at high doses of Wnt5aWT + Fz5 
(left).   
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Chapter 4: Conclusions & Future directions 
4.1. Introduction 
The recent crystal structure of xWnt8 bound to the CRD of mFz8 led to a prediction in 
the field that Wnt acylation plays a direct, and essential, role in CRD recognition (Janda 
et al., 2012). However, without in vivo validation of the crystallographic binding 
interfaces, it remained unclear whether the structure was an accurate reflection of the 
interactions between Wnts and CRDs occurring at the cell surface. In this work, I 
investigated the role of acylation in the biological activity of unique Wnts. I introduced 
point mutations to the acylated serine residues on Wnts 8, 1, 3a and 5a and compared 
their abilities to activate well-established Wnt signaling outcomes within the early 
Xenopus embryo.  
In Chapter 2, I first tested the ability of xWnt8 to activate the b-catenin dependent 
pathway when acylation was prevented. Surprisingly, I found that non-acylated xWnt8 
(S187A) was capable dorsalizing Xenopus embryos as well as activating the 
transcription of the Wnt-responsive genes Siamois and Xnr3. These data argued that 
xWnt8 may be capable of acylation-independent signaling. Therefore, I next asked 
whether xWnt8S187A were capable of interacting with Fz CRDs in vivo. I analyzed the 
interaction of xWnt8S187A with the CRD of xFz8 by co-immunoprecipitation. This assay 
confirmed that xWnt8 retains the ability to interact with CRDs when acylation is 
prevented. My data argued that, contrary to the prediction from the xWnt8/mFz8 CRD 
crystal structure, acylation is not absolutely required for the biological activity of xWnt8.  
Wnts are predicted to interact with Fzs through highly redundant mechanisms, 
which suggested that acylation-independent Wnt signaling might be a shared property of 
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the ligand family (Cong et al., 2004; Holmen et al., 2002; Janda et al., 2017). Therefore, 
in Chapter 3, I expanded my study to examine the role of acylation in activity of Wnts 1, 
3a and 5a. Wnts 1 and 3a, like Wnt8, selectively activate the b-catenin dependent 
pathway (McMahon and Moon, 1989; Sokol et al., 1991). I observed that Wnt3a, like 
xWnt8, demonstrated acylation-independent signaling and CRD binding. In contrast, 
Wnt1 could not activate the b-catenin dependent pathway when acylation was 
prevented. My results argued that Wnts have unique dependencies on acylation for their 
biological activity. Furthermore, they suggested these Wnts with redundant functional 
outcomes are structurally unique and might have unique requirements for binding CRDs. 
Finally, I examined the role of acylation in the signaling of Wnt5a, and activator of the 
PCP pathway. Wnt5a, like Wnt1, required acylation for its biological activity, 
demonstrating that neither acylation-dependent nor acylation-independent signaling is 
unique amongst the Wnt family.  
 
4.2. Structural requirements for acylation-independent Wnt/CRD binding 
My data reveal that Wnts 8 and 3a do not require acylation to activate the b-catenin 
dependent pathway in vivo. Furthermore, I demonstrate that these ligands may 
productively engage the xFz8 CRD even when binding between the acyl tail on the Wnt 
and the hydrophobic groove on the CRD is prevented. My observations are not the first 
evidence that signaling through Fzs can occur via mechanisms independent of the Site 1 
acyl/protein binding surface. The soluble ligands Norrin and WntD are both capable of 
engaging Fz4 in vivo (Xu et al., 2004; Ke et al., 2013; Shen et al., 2015; Chang et al., 
2015; McElwain et al., 2011) (Ching et al., 2008). Additionally, artificial Wnt agonists that 
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contain lipid-free Fz-binding and LRP-binding modules potently activate canonical Wnt 
signaling through Fzs 1, 2, 5, 7, and 8 (Janda et al., 2017). In sum, accumulating 
evidence supports to the hypothesis that Fzs have the capacity to engage both acylated 
and non-acylated ligands.  
What might an acylation-independent Wnt/Fz interaction look like? Evidence 
suggests that Site 2 may be a common ligand-binding interface on Fz CRDs. In Chapter 
2, I demonstrate that Site 2 is necessary for the biological activity of xWnt8. Introducing 
even one mutation (W319A) to the index finger of xWnt8 decreased signaling of the 
ligand by more than 500-fold. Furthermore, a “mini-Wnt” comprising only this index finger 
domain is shown to bind independently to the mFz8 CRD in vitro (Janda et al., 2012), 
predicting that Site 2 interactions could stabilize Wnt binding in absence of the 
acyl/protein interface at Site 1. Lastly, crystallographic evidence reveals that Norrin also 
binds to the mFz4 CRD at the Site 2 interface (Shen et al., 2015; Chang et al., 2015). 
Thus, I predict that the protein-protein binding surface at Site 2 may play a role in the 
acylation-independent signaling of xWnt8 and hWnt3a observed in this study. 
However, alone, the Site 2 interface is almost certainly insufficient for the 
stabilization of a heteromeric complex at the cell surface. xWnt8 binds at Site 2 with a 
buried surface area of ~400 Å and poor overall shape complementarity (Janda et al., 
2012). In contrast, the dimeric ligand Norrin simultaneously engages two Fz4 CRDs, with 
each Site 2 interface containing twice (~800 Å) the buried surface area seen for xWnt8 
(Chang et al., 2015). An examination of current Wnt structural data reveals that 
acylation-independent CRD binding may be stabilized at Site 1 through contacts 
involving the amino acids on the thumb of xWnt8. Structurally, the thumb is composed of 
a long b-hairpin, held together by disulfide bonds, with the acyl group attached at the tip 
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(Janda et al., 2012). In the xWnt8/mFz8 CRD crystal structure, the amino acids of the b-
hairpin engage in important protein-protein contacts with a surface immediately above 
acyl-binding groove on the CRD (Figure 1.4) (Janda et al., 2012). In the context of a 
non-acylated Wnt, the binding of these thumb residues to the CRD may be sufficient to 
stabilize the Site 2 interface.  
It is important to consider, however, that the character of the protein-protein 
interactions at Site 1 may differ significantly for the binding of a non-acylated Wnt. For 
wild-type xWnt8, the shape and orientation of the thumb are constrained by the 
interaction of the acyl tail with the hydrophobic pocket of the CRD. In contrast, a recent 
crystal structure of the thumb of WntD shows that this b-hairpin has significant 
conformational flexibility in its unbound, non-acylated state (Chu et al., 2013). Therefore, 
the binding of a non-acylated Wnt to a CRD may involve different, possibly even more 
extensive, protein-protein contacts at the Site 1 interface. Additionally, it is important to 
consider that the xWnt8/mFz8 crystal structure might represent a kinetically trapped 
structure or a ligand-binding intermediate and therefore not reflect the Wnt/CRD 
interactions occurring in vivo. Further structural characterization of acylation-
independent Wnt binding will be required to understand which surfaces play key roles in 
these processes. 
A combined in vitro and in vivo approach could be taken to test the role of 
protein-protein interfaces in acylation-independent Wnt binding. Previous efforts to purify 
and study wild-type Wnts have proven unsuccessful due to the requirement for 
detergent-solubilization of the acyl tail (Willert et al., 2003; Kurayoshi et al., 2007). 
However, biochemical studies may be successfully used to verify, and investigate the 
nature of, interactions between non-acylated Wnts and Fz CRDs. The Lemmon lab has 
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developed a successful protein purification method for DWnt5, a Drosophila Wnt that is 
not acylated when expressed from S2 cells (Lemmon, unpublished). The application of 
these methods to the purification of non-acylated mammalian Wnts could open an 
avenue to the biochemical study of Wnt/CRD interactions in vitro. These studies could 
also be expanded to include other Wnt-binding domains, such as the b-propeller motifs 
of LRP5/6 and the extracellular domains of RTKs. Using the Xenopus-based assay 
system developed in this thesis, future scientists would be able to translate structural 
predictions from biochemical assays into a physiological context. For example, mutating 
amino acids important for acylation-independent Wnt activity on xWnt8 S187A (or 
hWnt3a S209A) would be predicted to abolish the signaling of the ligand in vivo. 
 
4.3. Updated roles for acylation in Wnt signaling 
Acylation clearly plays an important role in Wnt signaling, even though our data argue 
that it is not absolutely required for productive receptor binding. Wnts 3a and 8, which 
are capable of robust acylation-independent activity, exhibit approximately ten-fold 
weaker signaling when acylation is prevented. The attenuated signaling of non-acylated 
Wnts explains why the biological activity of Wnt3a S209A was not detected in a previous 
study using a lower range of injected mRNA concentrations (Takada et al., 2006).  
Acylation is predicted contribute to the signaling of Wnts through multiple 
mechanisms. In many physiological contexts, Wnt secretion requires acylation-
dependent interactions with the cargo receptor Evi/Wntless (Herr and Basler, 2012). 
However, we were unable to verify a previous report which demonstrated that preventing 
acylation causes Wnts to accumulate in the endoplasmic reticulum of Xenopus embryos 
78	
	
(Figure 2.4, Takada et al., 2006). The early Xenopus embryo may provide a uniquely 
permissive environment for the secretion of non-acylated Wnts. The morpholino 
knockdown of xWntless affects the secretion and activity of Wnt4, but not Wnts 3a, 5a, 8 
or 11 during Xenopus development (Kim et al., 2009). However, the authors failed to 
account for a possible contribution of maternal transcripts to protein levels within the 
embryo, and thus a role for xWntless cannot be entirely ruled out. As a continuation of 
the work presented in this thesis, it will be imperative to directly compare the secretion 
and extracellular activity of acylated and non-acylated Wnts. For example, if xWnt8 
S187A is secreted and retains biological activity, these results would support to the 
hypothesis that non-acylated Wnts retain the ability productively engage Fz/LRP 
complexes. In contrast, if xWnt8 S187A is not secreted or not active in the extracellular 
space, then these data would argue that signaling may be occurring from the 
intracellular space through atypical mechanisms.  
Interestingly, the only difference we were able to detect between the cellular 
distributions of xWnt8WT and xWnt8S187A was in the association of ligand with the cell 
periphery. xWnt8WT accumulates at the boundary of Wnt-producing cells but this staining 
was largely absent in tissues expressing xWnt8S187A (Figure 2.4). It is well-documented 
that Wnts signal primarily through local, cell-to-cell mechanisms (Willert et al., 2003; 
Pfeiffer et al., 2002; Franch-Marro et al., 2008; Galli et al., 2007; Farin et al., 2016; Gao 
et al., 2011). Could the changes in the extracellular distribution of xWnt8 S187A account 
for its ten-fold shift in activity? Preventing the acylation of the Drosophila EGFR ligand 
Spitz causes significant signaling defects in vivo without altering ligand secretion or 
receptor affinity (Miura et al., 2006). Spitz, like Wnts, requires acylation to restrict ligand 
diffusion in the extracellular space. In doing so, acylation provides an important 
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mechanism for defining Spitz gradients, as it allows local ligand concentrations to 
accumulate to the thresholds required for EGFR activation to drive the correct patterning 
of the photoreceptors in the eye imaginal disc (Miura et al., 2006). These studies 
highlight the importance of acylation-dependent tethering in ligands that signal through 
local mechanisms and suggest that a tethering defect may explain the ten-fold shift in 
activity seen for Wnts 8 and 3a.  
However, defining the exact roles that acylation plays in Wnt signaling will prove 
to be quite a challenge. The fact that Spitz was amenable to purification and biochemical 
analysis allowed investigators to directly measure ligand affinities and conclude that 
acylation does not alter to the interaction of Spitz with Drosophila EGFR or other 
extracellular binding partners (Miura and Treisman, 2006). Thus, changes in 
extracellular distribution and tissue patterning of the ligand could reasonably be 
interpreted as pertaining to the role of acylation in gradient formation. Although the data 
presented in Chapters 2 and 3 argue that acylation is not absolutely required for 
productive CRD binding, we cannot rule out the possibility that acylation enhances the 
affinity of Wnts for CRDs. Receptor binding can also influence the diffusion of ligands 
within the extracellular space. For example, manipulating the levels of Fz expression 
alters the gradient of Wnt3a within the crypts of the small intestine (Farin et al., 2016). In 
sum, the diffusion of Wnts within the extracellular space may be influenced by their 
relative affinities for cell surface receptors as well as the tethering function of the acyl 
tail. Without the development of technologies that will allow for the direct measurement 
of the affinities of acylated Wnts for CRDs, we will not know the relative contributions of 
these processes to the biological activities of Wnts.  
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Alongside a clear requirement for continued biochemical analysis of Wnts, I 
suggest that future in vivo studies of Wnt acylation may benefit from the careful selection 
of biological systems. First, it is important to consider that chemical or mutagenesis-
based methods for preventing Wnt acylation may create a “dilution effect” at the cell 
membrane that will vary based on the volume of the extracellular space. For example, 
we observe acylation-independent activity of Wnt3a in early Xenopus embryos which 
have highly-restrictive tissue architecture. In contrast, acylation-independent Wnt3a 
signaling has not been detected in cell culture models where “untethered” ligands may 
diffuse over great distances (Zhang et al., 2015; Kakugawa et al., 2015). Second, the 
secretion of non-acylated Wnts is attenuated in most model systems from Drosophila to 
mammals due to a requirement for the cargo receptor Evi/Wntless (van den Heuvel et 
al., 1993; Chen et al., 2009; Rios-Esteves and Resh, 2013; Herr and Basler, 2012). 
Therefore, selecting a system that is permissive for the secretion of non-acylated Wnts 
may be critical for detecting their activity. There is some evidence to suggest that the 
Xenopus embryo may be a system that naturally supports the secretion of non-acylated 
Wnts (Kim et al., 2009). However, it may also be possible to engineer such a system by 
using CRISPR/Cas9 technologies to knockout the cargo receptor Evi/Wntless in other 
contexts.  
 
4.4 Structural differences between Wnts 
The data we present in Chapters 2 and 3 demonstrate that Wnts have different 
dependencies on acylation for their biological activities. Wnts 8 and 3a define a novel 
subclass of ligands which are capable of acylation-independent signaling. In contrast, 
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Wnts 1 and 5a absolutely require acylation for signaling in vivo. It is particularly 
noteworthy that we observe signaling differences between Wnts 1, 3a and 8, as current 
evidence points to these ligands being both structurally and functionally redundant. All 
three Wnts selectively activate the b-catenin dependent pathway through the 
engagement of Fz and LRP5/6 heterodimers (Nusse and Clevers, 2017). Furthermore, 
synergy studies performed in Xenopus embryos reveal that the acylated versions of 
these ligands have highly-overlapping affinities for individual Fzs (Deardorff et al., 2001). 
Yet, in their non-acylated forms, Wnts 1, 3a and 8 have surprisingly different biological 
activities. These data argue that Wnts activating the b-catenin dependent pathway are 
structurally diverse and may have fundamentally unique mechanisms for engaging Fzs 
at the cell surface.   
 How might structural differences between Wnts give rise to the unique biological 
activities I observe in vivo? Biochemical studies will almost certainly provide the most 
direct answer to this question. Within the embryo, the acylation state of individual Wnts 
may affect a variety of intracellular and extracellular interactions both known and 
unknown. However, if one assumes that the unique structural characteristics of Wnts 
directly relate to their ability to bind CRD-containing receptors, then three different 
hypotheses could explain the distinct biological activities of Wnts 8, 1, 3a and 5a 
observed in our assays.  
First, only select Wnts may contain the requisite structural features for acylation-
independent CRD binding. If true, I would predict that Wnts 8 and 3a contain certain 
protein elements, discussed in Section 4.2, allowing them to engage CRDs through 
acylation-independent mechanisms. In contrast, Wnts 1 and 5a would likely depend 
upon the sequestration of the acyl tail at the Site 1 interface to engage CRD-containing 
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receptors. This hypothesis might be tested in vivo by creating chimeric ligands of Wnt1 
and Wnt8, possibly by swapping thumb and index finger domains between the pair, in 
order to identify which parts of the protein are required for acylation-independent 
signaling.  
Second, all Wnts may be capable of both acylation-dependent and acylation-
independent CRD binding. Non-acylated Wnts may have different, possibly more 
specific, CRD affinities than their acylated counterparts. Under this hypothesis, I would 
predict that Wnt1 is also capable of acylation-independent signaling if it encounters the 
right receptor. This could be tested by examining the synergistic signaling of unique Wnt 
and Fz pairs in Xenopus embryos using both acylated and non-acylated versions of 
each ligand.  
Lastly, it is possible that Wnts only bind CRDs through acylation-independent 
mechanisms. It is interesting to note that the authors of the xWnt8/mFz8 CRD crystal 
structure were only able to capture this protein interaction under conditions where the 
CRD was expressed as an Fc fusion construct (Janda et al., 2012). If the acyl tails of 
Wnts are normally sequestered within the outer layer of the cell membrane, then forcing 
Wnt association with a soluble, dimeric CRD-Fc may have caused the acyl tail to 
become sequestered away from the aqueous environment in a non-physiological 
manner. If acylation does not directly contribute to receptor binding, then the unique 
biological activities of non-acylated Wnts observed in this study are likely a manifestation 
of the different binding affinities of Wnts for endogenous Fzs. Although cell-based 
binding assays argue that Wnt/Fz interactions lack specificity (Hsieh et al., 1999; 
Deardorff et al., 2001; Dijksterhuis et al., 2015), I suggest that the ability of the acyl tail to 
“concentrate” ligands at the cell membrane may mask real differences in affinity between 
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Wnt and Fz pairs. Testing this prediction, as described for the ligand Spitz (Miura and 
Treisman, 2006), will require the direct biochemical comparison of the affinities of 
acylated and non-acylated Wnts for CRDs.   
 
4.5 Signaling consequences of non-acylated Wnts 
The unique structural requirements for acylation within the Wnt family may translate into 
distinct signaling outcomes in vivo. Several recent studies have demonstrated that the 
secreted deacylase, Notum, enzymatically removes the acyl tail from Wnt ligands within 
the extracellular space (Kakugawa et al., 2015; Zhang et al., 2015). Extracellular 
deacylation may provide an important mechanism for shaping Wnt gradients in vivo. 
Long-range transport of active Wnts, although uncommon, could be achieved through 
the Notum-dependent “untethering” of Wnts from membranes. Deacylation may also 
provide a mechanism for remodeling the spatial and temporal boundaries of Wnt 
gradients. Expression of Notum at tissue boundaries could effectively “turn off” the 
signaling of certain Wnts, as seen for Wnts 1 and 5a in this study. Alternatively, 
deacylation could reveal distinct patterns of Fz binding, which may help to shape the 
responsiveness of specific cells within a tissue to extracellular Wnt.  
Notum is thought to bind to Wnts by specifically recognizing the unsaturated 
hydrophobic palmitoleic moiety covalently added to Wnts, suggesting that the enzyme 
will nonspecifically de-acylate all Wnts it encounters in vivo (Kakugawa et al., 2015). 
However, experiments I performed during my thesis argue that Notum likely also 
recognizes and engages Wnt proteins (Appendix, Figure 2). When I co-expressed 
Notum (both WT and an enzymatically dead S239A mutant) with xWnt8WT or xWnt8S187A 
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from the same cell of the Xenopus embryo, I observed inhibition of xWnt8S187A, which 
suggests a dominant-negative effect of Notum on Wnt function that is independent of 
lipid binding (Appendix Figure 2A, B). To investigate potential differences in the effect of 
Notum-mediated, extracellular deacylation on unique Wnts, I expressed NotumWT and 
xWnt8WT or mWnt1WT from separate cells of the embryo (Notum was injected at the 4-
cell stage, and Wnt at the 8-cell stage into an adjacent cell, Appendix Figure 2D, E). I 
observed very weak inhibition of both proteins in these assays, and was unable to draw 
any strong conclusions about the differential effect of extracellular deacylation on 
individual Wnts. In summary, the regulation of Wnt acylation by Notum may provide a 
mechanism to fine-tune Wnt gradients in vivo, but requires more study to determine the 
relative contributions of protein-binding and deacylation to its inhibitory effect on Wnts. 
 Targeting Wnt acylation for therapeutic purposes has become very attractive in 
the Wnt field. Particularly, inhibitors of the acyltransferase Porcupine demonstrate 
clinical promise in the treatment of cancers with Wnt-driven activation of the b-catenin 
dependent pathway (Proffitt et al., 2013; Chen et al., 2009; Kulak et al., 2015; Madan et 
al., 2016; Tammela et al., 2017). The inhibitor LGK974 is currently in phase one clinical 
trials for the treatment of triple negative breast cancer, pancreatic cancer, as well as 
many other malignancies (https://clinicaltrials.gov/ct2/show/NCT01351103). Although 
these drugs continue to show significant promise in the treatment of human disease, the 
work presented in this study urges a more nuanced evaluation of the effects of 
Porcupine inhibition on Wnt signaling. Although Porcupine inhibitors greatly reduce the 
secretion of Wnts, they do not completely abolish the transport of these ligands to the 
extracellular space (Proffitt et al., 2013; Chen et al., 2009). In Chapter 2, I demonstrate 
that Wnts lacking acylation are still able to productively bind CRDs and activate the b-
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catenin dependent pathway. In Chapter 3, my studies of the acylation-independent 
signaling of unique Wnts further predict that the effects of Porcupine inhibition will 
depend on the specific structural properties of the Wnt(s) and Wnt receptors expressed 
by cancer cells. In sum, my work highlights that continued research into the mechanisms 
that govern Wnt/receptor interaction will be important for our understanding of vertebrate 
development and the treatment of human disease. 
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Chapter 5: Materials & Methods 
 
5.1. Reagents 
Antibodies 
b-tubulin BD Pharmingen 556321 
xWnt8 Cocalico 
Biologicals 
Custom Ab 
137 µM 
Wnt1 abcam 15251 
Wnt3a abcam 28472 
Wnt5a Cell Signaling C27E8 
Myc 9E10 UPenn Cell 
Center 
3207 
Myc Cell Signaling 2272 
FLAG Thermofisher PA1-984B 
GFP abcam 13970 
Donkey a-Mouse 680 secondary Licor 925-68072 
Donkey a-Rab 800CW secondary Licor 925-32213 
Alexa Fluor 488 Goat a-Chicken IgY (H+L) 
secondary 
ThermoFisher A-11039 
Alexa Fluor 594 Goat a-Rabbit IgG (H+L) 
secondary 
ThermoFisher A-11012 
Chemicals, Peptides, and Recombinant Proteins 
Protease Inhibitor Cocktail Sigma P8340 
bløkä-FL	Fluorescent	Blocker Millipore WBAVDFL01 
Recombinant Protein G Agarose ThermoFisher 15920010 
Critical Commercial Assays 
mMessage mMachineä SP6 Transcription Kit ThermoFisher AM1340 
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RNeasy Mini Kit QIAGEN 74106 
M-MLV Reverse Transcriptase ThermoFisher 28025013 
Power SYBRä Green PCR Master Mix ThermoFisher 4367659 
EpiMAX Affinity Purification Kit abcam ab138915 
Oligonucleotides 
ODC_for:	5’	–	GATCATGCACATGTCAAGCC	–	3’		 Skirkanich et al., 
2011 
siamois Forward 
ODC_rev:	5’	–	TCTACGATACGATCCAGCCC	–	3’	 Skirkanich et al., 
2011 
siamois Reverse 
Siamois_for:	5’	–	CTGTCCTACAAGAGACTCTG	–	3’	 Iwasaki and 
Thomsen, 2014 
siamois U 
Siamois_rev:	5’	–	TGTTGACTGCAGACTGTTGA	–	3’	 Iwasaki and 
Thomsen, 2014 
siamois D 
Xnr3_for:	5’	–	
CTGGAGTCACCACAAATCTACCCAGA	–	3’	
Blythe et al., 2010 Xnr3 5’ Forward 
5’ 
Xnr3_rev:	5’	–	AGGCATCGCCATCAGTGGGG	–	3’	 Blythe et al., 
2010, #54228 
Xnr3 5’ Reverse 
5’ 
 
5.2. Experimental model and vertebrate animal handling 
In vitro fertilization, microinjection and culture of Xenopus laevis embryos were 
performed as previously described (Hazel et al., 2000). All Xenopus experiments were 
approved by the Institutional Animal Care and Use Committee at the University of 
Pennsylvania and conform to relevant regulatory standards. 
 
5.3. Plasmid construction and in vitro translation  
The pCS2-memGFP plasmid was a gift from the laboratory of John Wallingford and is 
described in (Wallingford et al., 2000). pCS2-Venus was constructed by cloning an 
88	
	
Nco1/EcoR1 fragment of pVENUS-C1 into pCS2. pCS2-xWnt8 is described in (Deardorff 
et al., 1998). pcDNA-Wnt3A was a gift from Marian Waterman (Addgene plasmid # 
35908). The open reading frame (start to stop codon only) of Wnt3A was amplified by 
PCR and cloned into pCS2 using restriction enzymes BamHI and XbaI. pCS2-mWnt1 
was a gift from the laboratory of Jean-Pierre Saint-Jeannet and is described in (Saint-
Jeannet et al., 1997). The open reading frame was PCR amplified and re-cloned into 
pCS2 using restriction enzymes EcoRI and XbaI in order to remove the 3’ and 5’ UTRs. 
pcDNA-mWnt5a was a gift from the laboratory of Ed Morrisey and the open reading 
frame (start to stop codon only) was PCR amplified and cloned into pCS2 using the 
restriction enzymes BamHI and XhoI. NotumWT-FLAG and NotumS239A-FLAG cDNAs in 
pCS2 were a gift from the laboratory of Xi He and are cited here (Zhang et al., 2015). 
Site-directed mutagenesis was used to introduce point mutations to Site 1 and Site 2. 
Capped mRNA was synthesized using the mMessage mMachineä SP6 Transcription Kit 
(ThermoFisher AM1340) and purified using an RNeasy Mini Kit (QIAGEN). 
 
5.4. Analysis of Wnt phenotypes in Xenopus laevis embryos 
Xenopus embryos were obtained by in vitro fertilization as previously described (Sive et 
al., 2000) and cultured at room temperature in 0.1 X Marc's Modified Ringer’s (MMR) 
buffer unless otherwise stated. All buffer recipes are described in the handbook by Sive 
et al. (Sive et al., 2000). Ectopic expression of Wnt constructs was achieved by 
microinjection of mRNAs. Groups of 20-30 individual embryos were randomly grouped 
and placed in 0.5 X MMR, 3% Ficoll at 12˚C, and microinjected at the four-cell stage, 
with the exception of experiments where Notum and Wnts were expressed from 
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separate cells of the embryo (specific protocol described below). All mRNAs were co-
injected with 300 pg of Venus YFP mRNA, and negative control groups were injected 
with YFP mRNA only. Biological replicates were obtained using embryos from unique 
parental crosses. At the gastrula stage, embryos were sorted for YFP expression (as a 
positive control for successful mRNA injection) under a fluorescence dissecting 
microscope. Discrepancies between sample sizes at the beginning and end of each 
analysis are due to attrition caused by either a failure of embryos to demonstrate YFP 
fluorescence (resulting in embryos being discarded from the analysis) or the death of 
embryos before phenotypes were analyzed.  
For Wnts 1, 3a and 8, 10 nl of mRNA was injected into the lower marginal zone (4 
o’clock) of one ventrally-fated blastomere (ventral marginal zone, VMZ). Wnt5a was co-
injected with Fz5 mRNA at the same location. At the tailbud stages, a numerical score 
was assigned to individual embryo phenotypes (normal phenotype = 0, partial axis 
duplication = 1, full axis duplication = 2, radial duplication = 3). For each treatment, 
phenotype scores from individuals across three (or more) biological replicates were 
summed. Dividing by the total number of individuals analyzed yielded a mean dorsal 
score, which falls on a 0 – 3 scale.  
Experiments with Wnt and Notum mRNA were carried out using an identical protocol 
except for what is noted here. For experiments where Wnts were co-expressed with 
Notum from the same cell, mRNAs were mixed and injected simultaneously into the 
VMZ of a four-cell stage embryo. For experiments where Wnt and Notum were 
expressed from separate cells, Notum mRNA was injected at the four-cell stage into the 
VMZ of one ventral blastomere. At the eight-cell stage, Wnt mRNA was injected into the 
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adjacent ventral blastomere, in the lower cell, in the same batch of embryos. Notum 
mRNA was co-injected with 500 pg of tdTomato (RFP) mRNA and Wnt was co-injected 
with 300 pg of YFP mRNA. At the neurula stage, embryos were evaluated for YFP and 
tdTomato expression (note that tdTomato expression is quite weak) and any embryos 
with significantly overlapping expression patterns were discarded. Phenotypes were 
analyzed as described above. 
For mWnt5a-dependent convergent extension phenotypes, 5 nl of mRNA was injected in 
the upper marginal zone (2 o’clock) of both dorsally-fated blastomeres. Embryo 
phenotypes were analyzed for convergent extension defects at the mid-neurula stage. 
For each treatment, the number of embryos displaying convergent extension defects 
across three biological replicates was summed and represented as percent of the total 
individuals analyzed.  
 
5.5. RT-PCR 
Embryos used for the analysis of Wnt target gene transcription were cultured and 
microinjected using the methods described above. Ten YFP-positive embryos were 
flash-frozen at the early gastrula stage (Nieuwkoop and Faber stage 10). mRNA was 
isolated from all ten embryos using an RNeasy Mini Kit (QIAGEN). Reverse transcription 
was performed using M-MLV Reverse Transcriptase (ThermoFisher) with 2 µg template 
mRNA for 1 h at 42˚C. Real-time PCR was performed with Power SYBRä Green PCR 
Master Mix (ThermoFisher) for 30 cycles using the primers listed below. Ornithine 
decarboxylase (ODC) served as a reference gene. All primers are listed in Section 5.1. 
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Data were analyzed using the Comparative CT Method (DDCT) of qPCR analysis. Due to 
variability in the magnitude of fold change across clutches from different parental 
crosses, DDCT values were calculated by normalizing our test samples to a positive 
control. For comparisons of wild-type and mutated Wnt activity, the DCT value from the 
sample injected with the highest dose of WT mRNA was used as the calibrating sample 
(500 pg of xWnt8WT and mWnt1WT, 100 pg of hWnt3aWT). For co-injection of Wnt and 
xFz8 CRD mRNA, the DCT value of the sample injected with 5 pg WntWT mRNA was 
used as the calibrating sample for all three Wnts. 
 
5.6. xWnt8 antibody development 
Peptides A (aa21 – 119) and B (aa197 – 308) from xWnt8 were expressed as MBP 
fusion proteins from the pMAL-c2X vector. Fusion proteins were grown in E. coli and 
purified using standard methods. Immunization of rabbits with both peptides A and B 
was performed by Cocalico Biologicals. The resulting antisera reacted with peptide B 
only. The antibody was purified and concentrated from antisera with the EpiMAX Affinity 
Purification Kit (Abcam) using immobilized Peptide B GST fusion protein as bait. The 
antibody recognizes Xenopus Wnt8 but not murine Wnt8. Representative Western blots 
demonstrating the specificity of the antibody are included in Appendix Figure 1. 
 
5.7. Western blotting 
Embryos used for the analysis of Wnt protein expression were cultured and 
microinjected using the methods described above. Five YFP-positive embryos were 
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flash-frozen at the mid gastrula stage (stage 10.5). Embryos were homogenized through 
a P200 pipet tip in 10 µl/embryo Lysis Buffer (20 mM Tris, pH 7.5, 1% Triton X-100, 
140 mM NaCl, 10% glycerol, 10 mM EDTA, 1 mM DTT) supplemented with protease 
inhibitor cocktail (Sigma P8340, 1:100 dilution). Lysates were centrifuged at 1000 x g for 
5 min to remove yolk protein, and subsequently at 14,000 rpm for 10 minutes to remove 
cellular debris. The lipid-free layer of supernatant was recovered and 1-2 embryo 
equivalents were loaded on to a 10% SDS-PAGE gel. Protein gels were run at 100V and 
transferred to a nitrocellulose membrane for 2 h at 350 mA. Membranes were blocked 
for 1 h in bløkä-FL Fluorescent Blocker (Millipore), and probed with antibodies against 
b-tubulin (BD Pharmingen 556321, 1:1000), FLAG (1:500), xWnt8 (see above, 0.14 
µg/ml), Wnt1 (Abcam 15251, 1:1000), Wnt3a (Abcam 28472, 20 µg/mL) and Wnt5a (Cell 
Signaling Technology C27E8, 1:1000). Blots were incubated with fluorescently-
conjugated secondary antibodies (LI-COR, 1:50,000) for 1 h, washed for at least 2 h 
(optimally overnight) in TBS-T, and visualized on a LI-COR Odyssey scanner. 
 
5.8. Immunoprecipitations 
5 nl of a mixture of mRNAs encoding the relevant Wnt variant and xFz8 CRD-myc was 
injected into both animal blastomeres of two-cell stage embryos with YFP mRNA as a 
control. For studies with xWnt8, 10 YFP-positive embryos were frozen for processing 
from each treatment group at the gastrula stage (stage 10.5). Embryos were 
resuspended in 100 µl immunoprecipitation (IP) buffer (25 mM Tris-HCl, pH 7.4, 150 mM 
NaCl, 1% Triton X-100 and 2 mM EDTA) supplemented with protease inhibitor cocktail 
(Sigma, 1:100 dilution) and homogenized through a P200 pipet tip. Lysates were 
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centrifuged at 1000 x g for 5 min to remove yolk protein, transferred to a new Eppendorf 
tube, and subsequently centrifuged at 14,000 rpm for 10 min to remove cellular debris. 
One embryo equivalent of whole cell lysate was collected as an ‘Input’ sample and 7 
embryo equivalents were used for IP. Each IP sample was pre-cleared for one hour with 
10 µl settled protein-G agarose (ThermoFisher Scientific) and incubated, rotating, 
overnight at 4˚C with 1 µg 9E10 a-myc antibody (UPenn Cell Center). Lysates were 
subsequently incubated for 2 h at 4˚C with 10 µl settled protein-G agarose. Beads were 
washed for 10 min in 700 µl cold IP buffer three times. Beads were subsequently 
resuspended in 15 µl of standard 2 X SDS loading buffer, and incubated for 5 min on a 
95˚C heat block. 12 µl of IP eluate was then run on a 10% SDS-PAGE gel alongside 
Input samples. Gels were run and transferred as described above. For hWnt3a IPs, 
twice the volume of Input and IP samples were loaded on gels. For Wnt1 IPs, 2 µg of 
9E10 a-myc antibody was used for the overnight immunoprecipitation. Both protocols 
were otherwise identical to that described for xWnt8. Membranes were blocked for 1 h in 
bløkä-FL Fluorescent Blocker (Millipore), and probed with antibodies against xWnt8 
(see above, 0.14 µg/ml), Wnt1 (Abcam 15251, 1:250), Wnt3a (Abcam 28472, 40 µg/ml). 
The mouse 9E10 a-myc antibody (UPenn Cell Center, 1:1000) was used to detect xFz8 
CRD-myc expression in Input samples. A rabbit a-myc antibody (Cell Signaling 2272, 
1:1000) was used to detect xFz8 CRD-myc in IP samples, as this protein runs at the 
same molecular weight as the 9E10 heavy chain. Blots were incubated with 
fluorescently-conjugated secondary antibodies (LI-COR, 1:20,000) for 1 h, washed for at 
least 2 h in TBS-T, and visualized using a LI-COR Odyssey scanner. 
5.9. Immunofluorescence 
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Two-cell stage embryos were injected with 5 nl of 100 ng/µl memGFP mRNA in both 
blastomeres. At the 32-cell stage, embryos were again injected with 5 nl of 200 ng/µl 
mRNA encoding xWnt8WT or xWnt8S187A in one cell closest to the animal pole. At the late 
blastula stage (stage 9), the animal tissues of the embryo were surgically removed, 
fixed, bleached and stained (Lee et al., 2008). Antibodies were used to detect GFP 
(Abcam 13970, 1:2000) and xWnt8 (see above, 6.9 µg/ml), with secondary antibodies 
Alexa Fluor 488 Goat a-Chicken for GFP (ThermoFisher Scientific A-11039) and Alexa 
Fluor 594 Goat a-Rabbit for xWnt8 (ThermoFisher Scientific A-11012). Imaging was 
performed using a Leica TCS SP8 Confocal microscope. Negative control embryos (not 
shown) were neither injected with xWnt8 nor memGFP but were processed alongside 
experimental samples and were used to determine the data acquisition parameters on 
the confocal microscope. The ‘levels’ function in Adobe Photoshop was used to perform 
linear contrast stretching equally in all images for clarity of viewing.  
 
5.10. Statistical Analysis 
Gene expression data were analyzed with STATA software (https://www.stata.com/). To 
analyze the relationship between mRNA treatment and gene expression, a fixed effects 
regression model treating the X variable (mRNA treatment type) as categorical was 
employed to account for clutch-to-clutch variation in gene expression values in all 
analyses. Two-tailed P values were used to determine significance. Statistical 
significance was set as follows: ‘ns’ denotes p ³ 0.05, *p £ 0.05, **p £ 0.01 and 
***p £ 0.001. Activation of Wnt-specific gene expression by the Site 1- and Site 2-
mutated proteins was analyzed using control samples (YFP mRNA-injected embryos) as 
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the reference group. Wnt 8, 1 and 3a dose curves were also analyzed using the control 
samples as a reference group. Subsequent pair-wise comparisons were performed 
using a Wald chi-squared test with (1, 24) degrees of freedom. To determine the effect 
of xFz8 CRD co-expression on Wnt-dependent transcription, each data set was first 
analyzed for interaction between the two treatment variables – Wnt type (WT or acyl 
mutant) and inhibitor (CRD) presence – but no significant interaction was found. Final 
analysis was performed using a regression model without interaction with the WT alone 
treatment group serving as a reference group.  
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Appendix 
Figure A1. An antibody derived from peptide B specifically recognizes xWnt8.  
Peptide A: 
ASAWSVNNFLMTGPKAYLTYSASVAVGAQNGIEECKYQFAWERWNCPESTLQLATHNGLRSAT
RETSFVHAISSAGVMYTLTRNCSMGDFDNCGCDDSRNHHHHHHHH* 
Peptide B:  
LQLAEFRDIGNHLKIKHDQALKLEMDKRKMRSGNSADNRGAIADAFSSVAGSELIFLEDSPDYCL
KNISLGLQGTEGRECLQSGKNLSQWERRSCKRLCTDCGLRVEEKKTEHHHHHHHH* 
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Figure A1. An antibody derived from peptide B specifically recognizes xWnt8.  
(A) The xWnt8 antibody Test bleed 1 detects peptide B and xWnt8 with high specificity. Peptides 
A and B were expressed as both maltose-binding protein (MBP) and glutathione-S transferase 
(GST) fusion proteins in E. coli. MBP constructs were chosen based on their higher solubility and 
purified over an amylose column using standard methods. On the left Western, purified MBP 
peptides were run in lanes 1 and 3. Whole cell lysates of E. coli expressing GST fusion proteins 
were run in lanes 2 and 4. Gels were run and transferred and probed with a 1:500 dilution of Test 
bleed 1 (November, 2013) as well as an anti-His-tag antibody. In the right Western, whole cell 
lysates derived from 293 cells transfected with 1 ng of plasmid DNA encoding YFP (lane A), 
mWnt8 (lane B) or xWnt8 (lane C) were probed with a 1:500 dilution of Test bleed 1. To note, 
mWnt8 expression was previously confirmed in these lysates by IP (experiment date: 1/31/13). 
(B) The purified xWnt8 antibody detects peptide B and xWnt8 in Xenopus lysates. The peptide B-
GST construct was expressed in E. coli, purified on a GST column using standard methods, and 
coupled to the column of an EpiMAX Affinity Purification Kit and used for the purification and 
concentration of the xWnt8 antibody. The resulting Ab (137 µM) was diluted 1:500 and used to 
confirm peptide B recognition (left). To ensure that the antibody specifically recognizes xWnt8 in 
Xenopus lysates, I injected 1 – 1000 pg of xWnt8-HA into embryos and probed whole cell lysates 
(right) with both the xWnt8 antibody and an HA epitope antibody.   
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Figure A2. Notum inhibits both acylated and non-acylated Wnt signaling. 
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Figure A2. Notum inhibits both acylated and non-acylated Wnts. Notum inhibits xWnt8WT, 
xWnt8S187A and mWnt1WT. For the experiments shown in A-C, Wnt and Notum mRNA were co-
injected into the VMZ of four-cell stage embryos. The dose of Wnt was held constant and a dose 
curve of NotumWT (dark green) or NotumS239A (light green) was co-injected. Mean dorsal scores 
were calculated for all treatment groups at the tailbud stages. Curiously, I found that (A) xWnt8WT 
– 1 pg (n=1), (B) xWnt8S187A – 50 pg (n=1) and (C) mWnt1WT – 2 pg (n=2) were all inhibited by 
both NotumWT and NotumS239A (enzymatically inactive version – Kakugawa et al., 2015). To 
eliminate any interactions between mRNAs or proteins within the cell, I next expressed Notum 
and Wnt from separate cells of the embryo. In the experiments shown in D – E, I injected Notum 
mRNA into a four-cell stage embryo at one ventral blastomere. Embryos received either YFP 
alone or 1000 pg NotumWT mRNA. I let these embryos develop until the eight-cell stage, when I 
injected both the YFP-only and NotumWT-expressing clutches with doses of either (D) xWntWT 
(n=3) or (E) mWnt1WT (n=3) mRNA concentrations between 0.5 – 10 pg at the neighboring ventral 
blastomere. Mean dorsal scores were calculated for all treatment groups at the tailbud stages. (F) 
NotumWT and NotumS239A are expressed equally in Xenopus embryos. Whole embryo lysates 
were obtained from Notum-expressing embryos and probed with an anti-FLAG antibody to detect 
the epitope tag on Notum. 
 
